<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="review-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2025.1659342</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Therapeutic roles and molecular mechanisms of Cuscutae Semen in reproductive diseases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Li</surname>
<given-names>Kun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1464926/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zheng</surname>
<given-names>Haixia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3122557/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hao</surname>
<given-names>Wenjie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kong</surname>
<given-names>Yanni</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhou</surname>
<given-names>Qianru</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>School of Pharmacy, Hangzhou Medical College</institution>, <addr-line>Hangzhou, Zhejiang</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College</institution>, <addr-line>Hangzhou, Zhejiang</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Center for Reproductive Medicine, Department of Traditional Chinese Medicine, Zhejiang Provincial People&#x2019;s Hospital (Affiliated People's Hospital), Hangzhou Medical College</institution>, <addr-line>Hangzhou, Zhejiang</addr-line>,&#xa0;<country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/24906/overview">Uday Kishore</ext-link>, United Arab Emirates University, United Arab Emirates</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1451417/overview">Md Sadique Hussain</ext-link>, Uttaranchal University, India</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1683845/overview">Yafei Guo</ext-link>, Capital Medical University, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Kun Li, <email xlink:href="mailto:likun@hmc.edu.cn">likun@hmc.edu.cn</email>; Qianru Zhou, <email xlink:href="mailto:zhouqianru@hmc.edu.cn">zhouqianru@hmc.edu.cn</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>09</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1659342</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>07</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>09</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Li, Zheng, Hao, Kong and Zhou.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Li, Zheng, Hao, Kong and Zhou</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Cuscutae Semen (CS), one of the herbs in traditional Chinese medicine, has been recorded for a long time and contains various bioactive compounds, including flavonoids, phenolic acids, lignans, and polysaccharides. These compounds contribute to the medicinal effects on reproductive health. This review examines the therapeutic applications of CS in male and female reproductive diseases, its toxicity, and potential herb-drug interactions. This study focused on the medicinal roles and possible molecular mechanisms of CS in the treatment of reproductive diseases, such as male and female infertility, premature ovarian insufficiency, recurrent spontaneous abortion, and polycystic ovary syndrome. This review examines the mechanisms by which CS regulates the hypothalamic-pituitary-gonadal axis, hormone levels, and key molecules and signaling pathways crucial for reproductive health. By elucidating the potential mechanisms of CS action in reproductive endocrine disorders, this study aimed to provide a scientific basis and evidence for its clinical application in these conditions. These findings provide insights into the molecular mechanisms by which CS has significant potential for treating a range of reproductive disorders.</p>
</abstract>
<kwd-group>
<kwd>Cuscutae Semen</kwd>
<kwd>herb</kwd>
<kwd>reproductive disease</kwd>
<kwd>infertility</kwd>
<kwd>premature ovarian insufficiency</kwd>
<kwd>recurrent spontaneous abortion</kwd>
<kwd>polycystic ovary syndrome</kwd>
<kwd>hypothalamus-pituitary-gonadal axis</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="93"/>
<page-count count="17"/>
<word-count count="7017"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Molecular Innate Immunity</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>
<italic>Cuscuta chinensis</italic> (<italic>C. chinensis</italic>) Lam., a member of the Convolvulaceae family, is widely used in traditional Chinese Medicine (TCM) to treat various diseases. As a tonic Chinese medicine, Cuscutae Semen (CS; Tusizi in Chinese) is known for its effects on nourishing the kidneys, replenishing essence, consolidating essence, reducing urine, calming the fetus, and improving eyesight (<xref ref-type="bibr" rid="B1">1</xref>). Furthermore, current research shows that CS also improves other diseases, such as Alzheimer&#x2019;s disease (<xref ref-type="bibr" rid="B2">2</xref>), osteoporosis (<xref ref-type="bibr" rid="B3">3</xref>), kidney yang deficiency syndrome (<xref ref-type="bibr" rid="B4">4</xref>), diabetic chronic kidney disease (<xref ref-type="bibr" rid="B5">5</xref>), and aging (<xref ref-type="bibr" rid="B6">6</xref>). It may exert its therapeutic effects by regulating delayed aging and the immune system (<xref ref-type="bibr" rid="B7">7</xref>) and inhibiting oxidation (<xref ref-type="bibr" rid="B8">8</xref>).</p>
<p>Furthermore, CS has been used to treat both male and female reproductive disorders (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). It is used to enhance male reproductive function (<xref ref-type="bibr" rid="B9">9</xref>) and treat female infertility, and was later explored to treat a series of other reproductive diseases, such as premature ovarian failure (<xref ref-type="bibr" rid="B10">10</xref>). Several studies have reported its application in the treatment of reproductive endocrine diseases (<xref ref-type="bibr" rid="B11">11</xref>&#x2013;<xref ref-type="bibr" rid="B14">14</xref>). In modern medicinal research, the chemical composition and potential drug activity of CS have become hot research topics (<xref ref-type="bibr" rid="B1">1</xref>). CS&#x2019;s traditional roles in &#x2018;kidney nourishment&#x2019; and &#x2018;essence replenishment&#x2019; are validated as mechanisms involving hypothalamus-pituitary-gonadal (HPG) axis regulation (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B15">15</xref>), antioxidant protection of reproductive cells (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>), and modulation of hormone receptors (ER&#x3b1;/AR) (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). For example, &#x2018;fetal stabilization&#x2019; correlates with flavonoid-mediated inhibition of trophoblast apoptosis via MAPK pathways (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>). However, the comprehensive and potential target molecules and signaling pathways of the underlying mechanisms from the perspective of molecular biology in modern medicine are not fully understood, although an array of efficacy studies of CS application in the treatment of reproductive endocrine diseases has been well documented. Therefore, this review attempts to bridge the gap between traditional knowledge and modern science, focusing on the treatment of reproductive endocrine diseases and the signaling pathways underlying the mechanisms of CS targets in the reproductive endocrine process. This study further clarifies the specific mechanism of action of Cuscutae and provides a scientific and sufficient theoretical basis for its clinical application in reproductive endocrine diseases.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Main reproductive disorders treated with CS.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1659342-g001.tif">
<alt-text content-type="machine-generated">Circular diagram is divided into five segments around a central circle labeled Cuscutae Semen. The segments list the treated reproductive diseases: male infertility, female infertility, premature ovarian insufficiency, recurrent spontaneous abortion, and polycystic ovary syndrome.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s2">
<label>2</label>
<title>The origin of CS for disease therapy</title>
<p>CS has been utilized as an herbal remedy, as documented in numerous classical studies of Chinese traditional medicine. CS, classified as a top-grade herb, was initially mentioned in <italic>Shennong&#x2019;s Herbal Classic</italic>, the earliest Chinese pharmacological work published during the Han Dynasty, and was considered a seminal text in TCM. <italic>Shennong&#x2019;s Herbal Classic</italic> enumerates Cuscutae and documents its primary medicinal effects, including tonifying the liver and kidneys, enhancing visual acuity, promoting fetal stability, and improving sperm quality (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B16">16</xref>). The medicinal properties of <italic>Cuscuta australis (C. australis)</italic> were further elucidated in <italic>Lei Gong processed medicinal solutions</italic>. The compatibility of Cuscutae with Astragalus terrestris (i.e., Astragalus membranaceus) was addressed in <italic>the Collected Works of Materia Medica</italic>. The role of CS in kidney yang and its relationship with reproductive essence were expounded in the <italic>Classified Canon</italic>. The application of <italic>C. australis</italic> in the treatment of infertility was noted in <italic>The Secret Records of the Stone Chamber</italic>. The use of <italic>C. australis</italic> in the treatment of female-related gynecological disorders has been discussed in the <italic>Golden Mirror of Medicine</italic>. The treatment of infertility was examined, and the use of <italic>C. australis</italic> was referenced in <italic>Medical Prescriptions</italic>. The application of <italic>C. australis</italic> was mentioned in <italic>The Outline of Jiyang</italic>, which discussed the treatment method involving <italic>Cuscutae chinensis</italic>, as well as the relationship between female infertility and menstrual disorders, and was explored in the medical prescriptions, <italic>The Complete Collection in a Plate of Pearls</italic>. These continuously experienced applications suggest that CS has evident efficacy in disease treatment.</p>
</sec>
<sec id="s3">
<label>3</label>
<title>Major Bioactive Compounds of CS</title>
<p>CS contains a variety of bioactive compounds (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>) that contribute to its medicinal properties (<xref ref-type="bibr" rid="B1">1</xref>). With the advancement of modern investigation methods and technologies, lignans such as sesamin (<xref ref-type="bibr" rid="B22">22</xref>) and polysaccharides, primarily composed of mannose, have been isolated, detected, and characterized (<xref ref-type="bibr" rid="B9">9</xref>). These compounds have various biological effects. CS is rich in secondary metabolites, including flavonoids, chlorogenic acids, and lignans (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>). UPLC-MS analysis identified 45 predominant phenolic compounds (<xref ref-type="bibr" rid="B23">23</xref>). Polysaccharides derived from CS exhibit kidney-nourishing and antioxidant properties (<xref ref-type="bibr" rid="B3">3</xref>). Chromatographic techniques have been employed to analyze and quantify their components, including flavonoids (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>) and sesamin (<xref ref-type="bibr" rid="B22">22</xref>). The total flavonoid content varies among species (<xref ref-type="bibr" rid="B27">27</xref>). Recent evidence has shown that substances in CS, including kaempferol, quercetin, apigenin, hyperin, astragalin, and quercitrin, have potential estrogenic effects (<xref ref-type="bibr" rid="B28">28</xref>). Additionally, different CS processes lead to different efficacious components (<xref ref-type="bibr" rid="B29">29</xref>). These findings provide a scientific basis for the medicinal applications of CS.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Predominant bioactive compounds in CS.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1659342-g002.tif">
<alt-text content-type="machine-generated">Circular diagram illustrating the composition of Cuscutae Semen, divided into segments labeled: Flavonoids, Phenolic Acid, Lignans, Polysaccharides, Fatty Acids, Terpenes, Alkaloids, Trace Elements, Amino Acids, Volatile Components, and Steroids.</alt-text>
</graphic>
</fig>
<sec id="s3_1">
<label>3.1</label>
<title>Flavonoids</title>
<p>Approximately 40 primary flavonoids have been identified in CS (<xref ref-type="bibr" rid="B1">1</xref>). Key flavonoids include quercitrin, quercetin, hyperoside, kaempferol, and astragalin (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B26">26</xref>). Flavonoids are characterized by a C6-C3-C6 structure derived from a parent nucleus, which influences their chemical properties. Most flavonoids form glycoside compounds when combined with sugars, and exhibit diverse medicinal activities. Research on flavonoids in CS began earlier, and these compounds are among the most extensively studied active ingredients (<xref ref-type="bibr" rid="B27">27</xref>).</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Phenolic Acids</title>
<p>More than 20 different phenolic acids have been identified in CS, with phenolic acids being the main components of <italic>C. australis</italic> (<xref ref-type="bibr" rid="B1">1</xref>). These compounds are characterized by multiple phenolic hydroxyl groups attached to the benzene ring. Phenolic acids are medicinally active ingredients that act as anti-inflammatory, antibacterial, and immune-boosting agents.</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Lignans</title>
<p>More than 20 different lignans have been identified in C. <italic>chinensis</italic> (<xref ref-type="bibr" rid="B1">1</xref>). Lignans are natural compounds produced through the oxidation and polymerization of phenylpropanoids and are characterized by a core structure containing one or more C6-C3 fundamental units. It is one of the primary bioactive components of <italic>C. chinensis</italic> (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>).</p>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Polysaccharides</title>
<p>CS contains several neutral heteropolysaccharides, such as galactose, glucose, mannose, rhamnose, arabinose, and xylose. Glycosidic bonds are linked to complex molecules. One notable polysaccharide derived from <italic>C. chinensis</italic> is the Cuscutae polysaccharide, which demonstrates a range of pharmacological benefits including antitumor and anti-aging properties, immune system modulation, blood glucose reduction, and lipid regulation (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B30">30</xref>).</p>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Fatty acids</title>
<p>Fatty acids are organic compounds composed of carbon, hydrogen, and oxygen, featuring extended carbon chains and carboxyl groups that are essential for biological functions. The fatty acid structure plays a crucial role in various biological processes.</p>
</sec>
<sec id="s3_6">
<label>3.6</label>
<title>Steroids</title>
<p>Steroids are organic compounds characterized by a fundamental structure consisting of a cyclopentane polyhydrophenanthrene nucleus. Among the four constituent rings, the steroid core exhibited various ring fusion patterns. The hydroxyl groups at the C-3 position often form chemical bonds with sugar molecules, resulting in compounds classified as glycosides.</p>
</sec>
<sec id="s3_7">
<label>3.7</label>
<title>Terpenes</title>
<p>Terpenoids are compounds derived from mevalonate, which contains diene units (C5 units) as fundamental structural components. The molecular framework of terpenoids is predominantly chain-like or cyclic, incorporating various functional groups, including alcohols, aldehydes, ketones, carboxylic acids, and esters.</p>
</sec>
<sec id="s3_8">
<label>3.8</label>
<title>Alkaloids</title>
<p>Alkaloids are naturally occurring nitrogen-containing compounds with basic properties. These compounds typically have complex ring structures and exert significant physiological effects. Alkaloids are the key active components of Cuscutae.</p>
</sec>
<sec id="s3_9">
<label>3.9</label>
<title>Trace elements</title>
<p>Research has revealed the presence of essential trace elements in Cuscutae, including Mn, Cu, Mn, Fe, Zn, P, and Se (<xref ref-type="bibr" rid="B31">31</xref>), with Mn and Zn being higher in dodder. Zn is also important for sperm motility.</p>
</sec>
<sec id="s3_10">
<label>3.10</label>
<title>Amino acids</title>
<p>CS contains various amino acids (<xref ref-type="bibr" rid="B32">32</xref>), including seven essential amino acids required by the human body: valine, threonine, isoleucine, phenylalanine, methionine, lysine, and leucine. In addition, two semi-essential amino acids, histidine and arginine, have been identified. Arginine is essential for spermatogenesis and improves sperm motility and concentration (<xref ref-type="bibr" rid="B33">33</xref>).</p>
</sec>
<sec id="s3_11">
<label>3.11</label>
<title>Volatile components</title>
<p>Volatile components are among the primary constituents of CS, a seed-based medicinal material rich in oil.</p>
<p>Diverse bioactive compounds in CS have multidimensional medicinal functions. Additionally, CS from C. <italic>chinensis</italic> and C. <italic>australis</italic> exhibit significant differences in their phenolic profiles, with hyperoside being predominant in C. <italic>chinensis</italic>, and kaempferol and astragalin in <italic>C. australis</italic> (<xref ref-type="bibr" rid="B24">24</xref>). However, recent studies have indicated that the seeds of <italic>C. australis</italic> the main medicinal product of <italic>C. australis</italic>, exhibit efficacy similar to that of C. chinensis (<xref ref-type="bibr" rid="B34">34</xref>), which belongs to the same subgenus and shares similar chemical composition and content, although earlier research primarily focused on <italic>C. chinensis</italic> as the origin of the dodder.</p>
<p>It is important to note that the major bioactive compounds of Cuscuta species can exhibit variability depending on several factors, including the specific species, the host plant it parasitizes, the geographical location where it grows, and prevailing environmental conditions. This inherent variability underscores the necessity of carefully specifying the Cuscuta species and its origin in both research investigations and therapeutic applications to ensure the consistency and reproducibility of results.</p>
</sec>
<sec id="s3_12">
<label>3.12</label>
<title>Material basis for medicinal effects</title>
<p>The bioactive compounds in CS exhibit therapeutic effects. Flavonoids are the primary material for treating premature ovarian insufficiency (POI) and recurrent spontaneous abortion (RSA) by modulating PI3K/AKT and inflammatory pathways (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B28">28</xref>). Kaempferol is the primary component of the Wuzi Yanzong Pill for Asthenozoospermia, including CS. Polysaccharides enhance sperm quality and testosterone levels in infertile males, likely through their antioxidant and kidney-nourishing effects (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B35">35</xref>). Lignans (e.g., sesamin) and phenolic acids synergistically regulate hormone receptors in reproductive disorders (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B24">24</xref>). Therefore, these bioactive compounds provide the material basis for the medicinal efficacy of CS in reproductive health therapy.</p>
</sec>
</sec>
<sec id="s4">
<label>4</label>
<title>Reproduction diseases treated by CS</title>
<sec id="s4_1">
<label>4.1</label>
<title>Male and female infertility</title>
<p>CS, particularly <italic>C. chinensis, is</italic> often incorporated into compound formulations and has been widely utilized for its potential benefits in the treatment of male and female infertility. The Jiawei Wuzi Yanzong Pill formulation combines Cuscutae with other herbs, such as wolfberry and raspberry, to nourish the liver and kidneys, replenish essence and blood, and address male infertility (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B36">36</xref>). CS is the most commonly used herb for the treatment of female infertility (<xref ref-type="bibr" rid="B14">14</xref>). Jiajian Congrong Cuscutae Pills are effective for treating menstrual disorders (<xref ref-type="bibr" rid="B37">37</xref>), endometrial hyperplasia (<xref ref-type="bibr" rid="B38">38</xref>), and cystic ovarian syndrome (<xref ref-type="bibr" rid="B39">39</xref>). Jiajian Shoutai Pills often combine Cuscutae with other tonics to strengthen the liver and kidneys, invigorate the spleen, and nourish the blood, making them effective for conditions such as fetal loss and miscarriage (<xref ref-type="bibr" rid="B40">40</xref>).</p>
<p>Recent evidence has provided insights into the efficacy and mechanism of CS in treating infertility (<xref ref-type="bibr" rid="B41">41</xref>&#x2013;<xref ref-type="bibr" rid="B43">43</xref>). Research has shown that CS can enhance sperm motility and membrane function <italic>in vitro</italic> and modulate the PPAR signaling pathway (<xref ref-type="bibr" rid="B44">44</xref>). indicating benefits for male fertility treatment (<xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B45">45</xref>). In animal models, it has been shown to enhance the reproductive ability of rats with kidney yang deficiency (<xref ref-type="bibr" rid="B18">18</xref>), suggesting a therapeutic effect on male infertility. CS has been associated with improvements in gynecological health, particularly in conditions associated with kidney deficiency. Its use in the treatment of infertility and menstrual disorders has been documented (<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B43">43</xref>); however, more rigorous scientific studies are required to validate these effects.</p>
<p>The action of CS in treating infertility includes nourishing the kidneys, regulating hormones (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B46">46</xref>&#x2013;<xref ref-type="bibr" rid="B48">48</xref>), antioxidant properties (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B49">49</xref>), and improving ovarian function (<xref ref-type="bibr" rid="B14">14</xref>). CS is primarily recognized in TCM for its ability to nourish the kidneys, which is crucial for reproductive health. Studies have shown that CS can improve sperm quality by enhancing sperm count, motility, and morphology (<xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B48">48</xref>). It is believed that CS can address various deficiencies, including kidney yin and yang deficiency, which can lead to male reproductive issues, such as low sperm count and decreased sperm motility (oligoasthenospermia). In women, CS is thought to regulate menstrual cycles and enhance ovarian function, thereby improving the uterine environment for implantation. It has been used to treat menstrual irregularities, endometrial hyperplasia, and premature ovarian failure (POF).</p>
</sec>
<sec id="s4_2">
<label>4.2</label>
<title>POI</title>
<p>CS has beneficial effects on POI (<xref ref-type="bibr" rid="B50">50</xref>). Specifically, its active components, particularly flavonoids such as quercetin, show promise in treating POI by modulating key signaling pathways and improving ovarian function. For instance, these compounds have been found to inhibit POI progression by modulating the PI3K-AKT signaling pathway. Flavonoids found in CS have been shown to enhance the expression of estrogen receptors in the hippocampus, hypothalamus, and pituitary gland (<xref ref-type="bibr" rid="B51">51</xref>) as well as luteinizing hormone (LH) receptors in the ovaries of stressed rats, suggesting a potential mechanism by which CS may support ovarian function (<xref ref-type="bibr" rid="B10">10</xref>). TCM formulations, such as the Bushen Culuan Decoction, have also shown promise in ameliorating POI by activating antioxidant pathways, which may help protect ovarian function (<xref ref-type="bibr" rid="B52">52</xref>). Furthermore, CS has been shown to improve ovulation disorders associated with kidney deficiency by promoting follicular development and increasing the number of secondary follicles (<xref ref-type="bibr" rid="B53">53</xref>).</p>
<p>CS and its active components, particularly flavonoids such as quercetin, show promise in the treatment of POI by modulating key signaling pathways and improving ovarian function (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B54">54</xref>). Compounds in CS, particularly quercetin and other flavonoids, have been found to inhibit POI progression by modulating the PI3K-AKT signaling pathway (<xref ref-type="bibr" rid="B10">10</xref>). This pathway is crucial for cell survival and growth, and its modulation may improve ovarian function and hormone levels. Other compounds, such as epicatechin, have shown potential for treating POI via the PI3K/AKT/Nrf2 pathway (<xref ref-type="bibr" rid="B52">52</xref>), further supporting the idea that various herbal treatments can target multiple mechanisms involved in ovarian health. TCM formulations containing CS have demonstrated efficacy in improving ovarian function and hormone levels in POI models. These formulations may affect multiple signaling pathways involved in POI, including the PI3K/Akt/mTOR Pathways (<xref ref-type="bibr" rid="B19">19</xref>), thereby reducing follicular atresia and enhancing ovarian reserve. CS exhibits a range of medicinal activities, including antioxidant (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B49">49</xref>), hepatoprotective (<xref ref-type="bibr" rid="B55">55</xref>), and modulation of arachidonic acid, glycerophospholipid, and linoleic acid metabolism, as well as steroid hormone biosynthesis (<xref ref-type="bibr" rid="B56">56</xref>), which may contribute to its therapeutic potential in the treatment of POI. Other herbal medicines, such as Bushen Huoxue, also act on POI by regulating the TGF-&#x3b2;1 and Smad2/3 signaling pathways (<xref ref-type="bibr" rid="B52">52</xref>). CS combined with acupuncture may be beneficial in treating POI, including normalizing menstrual cycles and improving hormone levels, as meta-analyses suggest that this combination may be more effective than hormone replacement therapy in managing symptoms associated with POI (<xref ref-type="bibr" rid="B50">50</xref>). However, further high-quality clinical trials are necessary to confirm these findings and to establish the efficacy and safety of herbal treatments for POI.</p>
</sec>
<sec id="s4_3">
<label>4.3</label>
<title>RSA</title>
<p>CS has shown promising effects in the treatment of RSA and in enhancing overall reproductive health (<xref ref-type="bibr" rid="B13">13</xref>). Research indicates that flavonoids in CS play a key role in this effect by regulating inflammatory pathways and promoting trophoblast cell invasion, which are crucial for maintaining a healthy pregnancy (<xref ref-type="bibr" rid="B20">20</xref>). Studies have demonstrated that flavonoids in CS effectively modulate inflammatory responses (<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>). This regulation is essential for creating a favorable environment for implantation and fetal development, thereby reducing the risk of spontaneous abortion. In animal models of abortion, CS influences the expression of important proteins, such as Fas, PCNA, and HB-EGF (<xref ref-type="bibr" rid="B59">59</xref>). These proteins are involved in cell survival, proliferation, and trophoblast function, suggesting that CS may help maintain pregnancy by enhancing trophoblast activity. CS also exhibits anti-osteoporosis effects in ovariectomized mice (<xref ref-type="bibr" rid="B3">3</xref>), indicating its potential to improve bone health under postmenopausal conditions. Flavonoids from CS can ameliorate ovarian endocrine dysfunction, particularly in stressed female rats. CS may help restore hormonal balance and improve ovarian function by modulating hormone receptor expression (<xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B61">61</xref>), thus further supporting reproductive health.</p>
</sec>
<sec id="s4_4">
<label>4.4</label>
<title>Polycystic ovary syndrome (PCOS)</title>
<p>A recent study demonstrated the effects of CS in an established PCOS rat model (<xref ref-type="bibr" rid="B62">62</xref>). Another study demonstrated that CS, when combined with Salvia, regulates ten core genes involved in PCOS treatment, including IL6, AKT1, VEGFA, TP53, TNF, MAPK1, JUN, EGF, CASP3, and EGFR (<xref ref-type="bibr" rid="B63">63</xref>). The experimental animals exhibited abnormalities in the HPG axis, and the administration of varying doses of total flavonoids from CS to PCOS model rats resulted in significant improvements in pathological manifestations. Notably, serum E2 levels were significantly increased, whereas the ovarian index was reduced, indicating a positive effect on ovarian function. CS may play a role in regulating hormonal fluctuations associated with the menstrual cycle because the total flavonoids from CS were found to enhance the concentration of &#x3b2;-endorphin (&#x3b2;-EP) during the luteal phase, which subsequently decreased rapidly (<xref ref-type="bibr" rid="B15">15</xref>). CS have been shown to upregulate serum E2 levels and enhance the function of human chorionic gonadotropin (hCG) (<xref ref-type="bibr" rid="B64">64</xref>). This evidence suggests that CS may be involved in PCOS pathogenesis. However, it is important to note that CS did not have a significant effect on FSH receptor (FSHR) expression in ovaries (<xref ref-type="bibr" rid="B60">60</xref>). Collectively, CS may be beneficial for the treatment of polycystic ovary syndrome by improving hormonal balance and ovarian function. Further research is needed to fully understand the mechanisms and clinical implications of CS in PCOS management.</p>
</sec>
<sec id="s4_5">
<label>4.5</label>
<title>Clinical evidence on CS treatments for reproductive disorders</title>
<p>Some clinical evidence involving CS is emerging, while most research on CS is preclinical in nature. Meta-analyses support CS-containing formulations for reproductive disorders, although treatments using CS alone have been less investigated. A recent meta-analysis systematically evaluated the effectiveness of CS-containing Wuzi Yanzong pills in the treatment of oligoasthenospermia in male infertility. The analysis included a total of 16 studies involving 1960 patients, demonstrating that the Wuzi Yanzong pill alone is superior to Western medicine in improving sperm density, sperm motility, conjugal pregnancy rate, and total effective rate (<xref ref-type="bibr" rid="B65">65</xref>). The effect of CS contributed to the main role of the Wuzi Yanzong pill because the predominant composites in the formulation were derived from CS, as detected by modern technology (<xref ref-type="bibr" rid="B25">25</xref>).</p>
<p>Moreover, a Taiwanese cohort study identified CS as the most commonly prescribed herb for addressing female infertility (<xref ref-type="bibr" rid="B41">41</xref>), and a meta-analysis reported that CS were the most frequently observed cases with kidney deficiency acts as a &#x201c;reinforcing yang herb&#x201d; to strengthen the liver and kidney, and indicated that herbal medicine significantly boosted pregnancy rates when compared to placebo treatments (<xref ref-type="bibr" rid="B43">43</xref>). Another meta-analysis suggested that CS combined with acupuncture may be more effective than hormone replacement therapy for managing POI symptoms (<xref ref-type="bibr" rid="B50">50</xref>). Moreover, CS, as one of the important Chinese herbs, was discussed in a meta-analysis to have potentially beneficial effects on the perinatal outcomes of pregnant women in clinical applications (<xref ref-type="bibr" rid="B51">51</xref>).</p>
<p>In addition to the meta-analysis, a clinical trial involving a CS-containing formula, designed as a multicenter, randomized, double-anonymized, placebo-controlled study, has been conducted as a therapeutic option for reviving residual follicles in POI, and the study presented a promising strategy to delay ovarian decline and produce significant clinical evidence (<xref ref-type="bibr" rid="B66">66</xref>).</p>
<p>However, clinical trials on single CS therapy are lacking, except for clinical trials on formulations containing CS. Meanwhile, the methodological quality of the RCTs may have been poor, although the risk of bias in the included RCTs was generally low. Therefore, more high-quality clinical trials are required to confirm these findings.</p>
</sec>
</sec>
<sec id="s5">
<label>5</label>
<title>Molecular mechanisms by which CS play the medicinal roles in treating reproductive diseases</title>
<sec id="s5_1">
<label>5.1</label>
<title>Effects of CS on reproductive endocrine</title>
<p>CS has garnered attention for its medicinal effects on the reproductive system, particularly through its influence on the hypothalamus-pituitary-gonadal (HPG) axis (<xref ref-type="bibr" rid="B60">60</xref>). This intricate neuroendocrine system, comprising the hypothalamus, pituitary gland, and gonads (ovaries or testes), serves as the primary regulatory center for reproductive hormone production and secretion, and plays a vital role in controlling reproductive functions (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>CS plays a medicinal role in reproductive diseases via the hypothalamus-pituitary-gonadal axis and hormones. E, Estrogen; FSH, Follicle-Stimulating Hormone; LH, Luteinizing Hormone; P4, Progesterone; T, Testosterone; HCG, Human Chorionic Gonadotropin.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1659342-g003.tif">
<alt-text content-type="machine-generated">Flowchart illustrating the hormonal regulation of CS (Cuscutae Semen) on reproductive functions. It displays pathways involving the hypothalamus, pituitary gland, testis, and ovary. Hormones like FSH, LH, T, E, P4, and HCG are depicted. Processes include spermatogenesis, ovulation, and embryo development. Areas labeled with CS indicate Cuscutae Semen's therapeutic roles in reproductive diseases like infertility, premature ovarian insufficiency, recurrent spontaneous abortion, and polycystic ovary syndrome are highlighted at the bottom.</alt-text>
</graphic>
</fig>
<sec id="s5_1_1">
<label>5.1.1</label>
<title>HPG axis</title>
<p>CS modulates the HPG axis to regulate reproductive health. Specifically, studies have shown that CS total flavonoids promote the synthesis and secretion of gonadotropin-releasing hormone (GnRH) from the hypothalamus (<xref ref-type="bibr" rid="B67">67</xref>).</p>
</sec>
<sec id="s5_1_2">
<label>5.1.2</label>
<title>Hypothalamus</title>
<p>The hypothalamus plays a crucial role in regulating endocrine activity by secreting GnRH, which acts on the pituitary gland to stimulate the synthesis of prolactin and gonadotropic hormones (<xref ref-type="bibr" rid="B68">68</xref>). Under stressful conditions, corticotropin-releasing factor (CRF) inhibits GnRH synthesis, leading to reproductive dysfunction. As mentioned above, flavonoids from CS decrease the content of beta-EP in the hypothalamus (<xref ref-type="bibr" rid="B15">15</xref>).</p>
</sec>
<sec id="s5_1_3">
<label>5.1.3</label>
<title>Pituitary</title>
<p>The pituitary gland synthesizes and secretes FSH and LH, which are essential for steroid production in the gonads. Furthermore, flavonoids from CS increase LH levels in the anterior pituitaries (<xref ref-type="bibr" rid="B15">15</xref>). Another study showed that the modified Congrong Tusizi pill containing CS also enhances the function of the HPG axis by improving the pituitary response to GnRH from the upstream hypothalamus (<xref ref-type="bibr" rid="B69">69</xref>). However, the mechanism by which CS directly influences the pituitary gland requires further study.</p>
</sec>
<sec id="s5_1_4">
<label>5.1.4</label>
<title>Gonads</title>
<p>In males, LH promotes the differentiation of Leydig cells, leading to androgen production in the testes, whereas FSH stimulates spermatogenesis. Evidence also shows that CS increases testicular, epididymal, and pituitary weights and stimulates testosterone and LH secretion in rats (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B70">70</xref>).</p>
<p>In females, hormones and their receptors are critical for follicular growth. Upstream signals triggered by total flavonoids from CS can lead to a significant increase in E2, LH, and hCG levels as well as changes in FSHR receptors (<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B60">60</xref>), and can promote the ovarian response during the maturation of dominant follicles and increased proliferation of follicular granulosa cells (<xref ref-type="bibr" rid="B69">69</xref>).</p>
</sec>
</sec>
<sec id="s5_2">
<label>5.2</label>
<title>Involvement of CS in diverse signaling pathways</title>
<p>CS exerts various medicinal effects on the reproductive system by regulating specific molecules and signaling pathways. The different pathways are illustrated in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref> and summarized in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>. This section outlines the key targeted molecules and signaling pathways influenced by CS, highlighting its potential mechanisms of action in reproductive health.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Cell signaling by which CS plays a medicinal role in treating reproductive diseases. Abbreviation: AR, Androgen Receptor; BAD, Bcl-2-Associated Death Promoter; BAX, Bcl-2-Associated X Protein; BCL2, B Cell Lymphoma 2; CASP3, Caspase-3; CCND1, Cyclin D1; COX, Cyclooxygenase; DNMT3L, DNA Methyltransferase 3-Like; EGF, Epidermal Growth Factor; EGFR, Epidermal Growth Factor Receptor; ER, Estrogen receptor; FOS, FBJ murine osteosarcoma viral oncogene homolog; HIF-1, Hypoxia-Inducible Factor-1; HIF1A, Hypoxia-Inducible Factor 1-Alpha; IL6, Interleukin-6; IR, Insulin Receptor; JUN, Jun oncogene; MAPK, Mitogen-Activated Protein Kinase; MMP9, Matrix Metalloproteinase 9; MYC, myelocytomatosis oncogene; NF-&#x3ba;B, Nuclear Factor-Kappa B; Nrf2, Nuclear Factor Erythroid 2-Related Factor 2; OPG, Osteoprotegerin; PI3K, Phosphatidylinositol 3-Kinase; TNF-&#x3b1;, RANKL, Receptor Activator of Nuclear Factor-&#x3ba;B ligand; Tumor Necrosis Factor-Alpha; TP53, TR, Thyroid hormone receptor; Tumor Protein P53; TRACP-5b, Tartrate-resistant Acid Phosphatase 5b; VEGFA, Vascular Endothelial Growth Factor A; TRACP-5b, Tartrate-resistant Acid Phosphatase 5b; VEGFA, Vascular Endothelial Growth Factor A.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1659342-g004.tif">
<alt-text content-type="machine-generated">Diagram illustrating that CS (Cuscutae Semen) is involved in diverse cellular signaling pathways. Labels in different colors show different signaling pathways: inflammatory signaling, apoptosis and cell death pathways, metabolic pathways, gene regulation, epigenetic modifications, cellular markers, tumorigenesis and progression, growth factor signaling, and other potential signals.</alt-text>
</graphic>
</fig>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Signaling pathways, molecules, and their functions involved in the pharmacological roles of CS.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="center">Signaling pathways</th>
<th valign="middle" align="center">Molecules</th>
<th valign="middle" align="center">Functions</th>
<th valign="middle" align="center">References</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" rowspan="6" align="left">Growth Factor Signaling</td>
<td valign="middle" align="left">EGFR and EGF</td>
<td valign="middle" align="left">Epidermal growth factor receptor signaling</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B71">71</xref>, <xref ref-type="bibr" rid="B72">72</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">VEGFA</td>
<td valign="middle" align="left">Vascular endothelial growth factor signaling</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B71">71</xref>, <xref ref-type="bibr" rid="B72">72</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Insulin</td>
<td valign="middle" align="left">Insulin receptor signaling</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B73">73</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">AR</td>
<td valign="middle" align="left">Androgen signaling</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B18">18</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Estrogen Receptor</td>
<td valign="middle" align="left">Estrogen receptor signaling</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B74">74</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Thyroid Hormone Receptor</td>
<td valign="middle" align="left">Thyroid hormone receptor signaling</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B47">47</xref>)</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">Proliferation and Differentiation Signaling</td>
<td valign="middle" align="left">PI3K/Akt and MAPK</td>
<td valign="middle" align="left">Cell growth and survival</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B54">54</xref>, <xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B76">76</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Notch</td>
<td valign="middle" align="left">Cell fate determination</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B20">20</xref>)</td>
</tr>
<tr>
<td valign="middle" rowspan="3" align="left">Cellular Stress and Survival Signaling</td>
<td valign="middle" align="left">Calcium</td>
<td valign="middle" align="left">Calcium signaling</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B76">76</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Nrf2</td>
<td valign="middle" align="left">Nrf2 pathway activation, antioxidant response signaling</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B78">78</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">HIF-1 and HIF1A</td>
<td valign="middle" align="left">HIF1A hypoxia response signaling</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B13">13</xref>)</td>
</tr>
<tr>
<td valign="middle" rowspan="3" align="left">Inflammatory Signaling</td>
<td valign="middle" align="left">NF-&#x3ba;B</td>
<td valign="middle" align="left">Inflammatory response and immune regulation</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B79">79</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">TNF-&#x3b1;</td>
<td valign="middle" align="left">Tumor necrosis factor signaling</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B79">79</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Oxidative Stress Molecules</td>
<td valign="middle" align="left">Pathway response to oxidative stress</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B54">54</xref>, <xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B78">78</xref>, <xref ref-type="bibr" rid="B79">79</xref>)</td>
</tr>
<tr>
<td valign="middle" rowspan="5" align="left">Apoptosis and Cell Death Regulation</td>
<td valign="middle" align="left">BAD, BAX, Cleaved CASP3, CASP3</td>
<td valign="middle" align="left">Inducers of apoptosis and cell death regulation</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B80">80</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Cleaved CASP3,</td>
<td valign="middle" align="left">Apoptosis and cell death regulation</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B54">54</xref>, <xref ref-type="bibr" rid="B58">58</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Bax</td>
<td valign="middle" align="left">Regulation of pro-apoptotic protein Bax</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B54">54</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">BCL2</td>
<td valign="middle" align="left">Anti-apoptotic protein</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B46">46</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">SCF/c-kit-PI3K-Bcl2</td>
<td valign="middle" align="left">Survival signaling pathway</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B48">48</xref>)</td>
</tr>
<tr>
<td valign="middle" rowspan="6" align="left">Tumorigenesis and Progression</td>
<td valign="middle" align="left">MYC</td>
<td valign="middle" align="left">Cell cycle regulation</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B74">74</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Proteoglycans</td>
<td valign="middle" align="left">Tumor biology</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B13">13</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">COX</td>
<td valign="middle" align="left">Cancer and inflammation</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B79">79</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">IL6</td>
<td valign="middle" align="left">Cytokine involved in cancer progression</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B72">72</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">CCND1</td>
<td valign="middle" align="left">Cell cycle regulation</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B72">72</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Ki67</td>
<td valign="middle" align="left">Proliferation marker in cancer</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B42">42</xref>)</td>
</tr>
<tr>
<td valign="middle" rowspan="11" align="left">Metabolism<break/>Pathways</td>
<td valign="middle" align="left">Tryptophan</td>
<td valign="middle" align="left">Pathways involving tryptophan</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B82">82</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Phenylalanine</td>
<td valign="middle" align="left">Pathways involving phenylalanine</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B82">82</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Lysine and Vitamin B6</td>
<td valign="middle" align="left">Amino acid degradation and vitamin metabolism</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B4">4</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Taurine and Hypotaurine</td>
<td valign="middle" align="left">Taurine metabolism</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B4">4</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Arachidonic Acid</td>
<td valign="middle" align="left">Inflammatory processes</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B83">83</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Sphingomyelin</td>
<td valign="middle" align="left">Lipid metabolism related to cellular membranes</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B4">4</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Starch and Sucrose</td>
<td valign="middle" align="left">Carbohydrate breakdown</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B4">4</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Glucose Transporter</td>
<td valign="middle" align="left">Regulation of glucose uptake</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B81">81</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Primary Bile Acid</td>
<td valign="middle" align="left">Synthesis of bile acids</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B4">4</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Steroid Hormone</td>
<td valign="middle" align="left">Synthesis of steroid hormones</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B4">4</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Terpenoid Backbone</td>
<td valign="middle" align="left">Synthesis of terpenoids</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>)</td>
</tr>
<tr>
<td valign="middle" rowspan="3" align="left">Gene Regulation</td>
<td valign="middle" align="left">TP53</td>
<td valign="middle" align="left">Tumor suppressor and transcription factor</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B71">71</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">FOS</td>
<td valign="middle" align="left">Immediate early gene and transcription factor</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B84">84</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">JUN</td>
<td valign="middle" align="left">Transcriptional regulation</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B88">88</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Epigenetic<break/>Modification</td>
<td valign="middle" align="left">DNMT3 L</td>
<td valign="middle" align="left">Epigenetic regulation</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B73">73</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Cellular Markers and Indicators</td>
<td valign="middle" align="left">TRACP-5b</td>
<td valign="middle" align="left">Marker for bone resorption</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B86">86</xref>, <xref ref-type="bibr" rid="B87">87</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Cellular Functions and Modulation</td>
<td valign="middle" align="left">Endothelial Function Modulation Proteins</td>
<td valign="middle" align="left">Regulation of endothelial cell function</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B72">72</xref>)</td>
</tr>
<tr>
<td valign="middle" rowspan="6" align="left">Other potential signals</td>
<td valign="middle" align="left">MMP9</td>
<td valign="middle" align="left">Tissue remodeling</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B20">20</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Occludin</td>
<td valign="middle" align="left">Cell adhesion</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B88">88</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Osteoprotegerin (OPG)</td>
<td valign="middle" align="left">Metabolism</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B86">86</xref>&#x2013;<xref ref-type="bibr" rid="B88">88</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Receptor Activator of Nuclear Factor-&#x3ba;B (RANKL)</td>
<td valign="middle" align="left">Bone remodeling</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B86">86</xref>&#x2013;<xref ref-type="bibr" rid="B88">88</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Cytokine</td>
<td valign="middle" align="left">Immune modulation</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B79">79</xref>)</td>
</tr>
<tr>
<td valign="middle" align="left">Cholinergic</td>
<td valign="middle" align="left">Immune modulation</td>
<td valign="middle" align="left">(<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B89">89</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>AR, Androgen Receptor; BAD, Bcl-2-Associated Death Promoter; BAX, Bcl-2-Associated X Protein; BCL2, B Cell Lymphoma 2; CASP3, Caspase-3; CCND1, Cyclin D1; COX, Cyclooxygenase; DNMT3L, DNA Methyltransferase 3-Like; EGF, Epidermal Growth Factor; EGFR, Epidermal Growth Factor Receptor; FOS, FBJ murine osteosarcoma viral oncogene homolog; HIF-1, Hypoxia-Inducible Factor-1; HIF1A, Hypoxia-Inducible Factor 1-Alpha; IL6, Interleukin-6; JUN, Jun oncogene; MAPK, Mitogen-Activated Protein Kinase; MMP9, Matrix Metalloproteinase 9; MYC, myelocytomatosis oncogene; NF-&#x3ba;B, Nuclear Factor-Kappa B; Nrf2, Nuclear Factor Erythroid 2-Related Factor 2; PI3K, Phosphatidylinositol 3-Kinase; TNF-&#x3b1;, Tumor Necrosis Factor-Alpha; TP53, Tumor Protein P53; TRACP-5b, Tartrate-resistant Acid Phosphatase 5b; VEGFA, Vascular Endothelial Growth Factor A; TRACP-5b, Tartrate-resistant Acid Phosphatase 5b; VEGFA, Vascular Endothelial Growth Factor A.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec id="s5_2_1">
<label>5.2.1</label>
<title>Growth factor signaling</title>
<p>CS affects growth factor signaling, which is vital for cell proliferation and differentiation. There are many different signaling molecules, including EGFR, EGF (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B71">71</xref>, <xref ref-type="bibr" rid="B72">72</xref>), VEGF (<xref ref-type="bibr" rid="B71">71</xref>, <xref ref-type="bibr" rid="B72">72</xref>), insulin receptor (<xref ref-type="bibr" rid="B73">73</xref>), androgen receptor (AR) (<xref ref-type="bibr" rid="B18">18</xref>), estrogen receptor (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B74">74</xref>), and thyroid hormone receptor (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B74">74</xref>). CS can promote the development and function of reproductive tissues by enhancing the activity of growth factors.</p>
</sec>
<sec id="s5_2_2">
<label>5.2.2</label>
<title>Proliferation and survival signaling</title>
<p>CS may enhance the activation of this pathway, promoting cell proliferation and survival in reproductive tissues via the PI3K/AKT Pathway, which is involved in cell survival, growth, metabolism (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B48">48</xref>, <xref ref-type="bibr" rid="B54">54</xref>, <xref ref-type="bibr" rid="B70">70</xref>), and cancer (<xref ref-type="bibr" rid="B75">75</xref>). CS may modulate the mitogen-activated protein kinase (MAPK) pathway, which plays a significant role in cell differentiation and response to growth factors (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B54">54</xref>, <xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B76">76</xref>), thereby influencing cellular responses in the reproductive system. Furthermore, CS activates the Notch signaling pathway (<xref ref-type="bibr" rid="B20">20</xref>), which is essential for cell fate determination and differentiation. This pathway may be involved in ovarian function and follicular development. Furthermore, CS flavonoids activate the Notch/AKT/MAPK signaling pathway, which plays a role in the treatment of ovarian endocrine and reproductive disorders (<xref ref-type="bibr" rid="B20">20</xref>). Moreover, CS affects several key signaling pathways that are critical for cellular responses to external stimuli, stress, and survival signals. The relieved stress may be involved in protecting testicular tissues (<xref ref-type="bibr" rid="B77">77</xref>). These include calcium (<xref ref-type="bibr" rid="B76">76</xref>), Nrf2 (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B78">78</xref>), HIF-1, and HIF1A (<xref ref-type="bibr" rid="B13">13</xref>).</p>
</sec>
<sec id="s5_2_3">
<label>5.2.3</label>
<title>Inflammatory signaling</title>
<p>CS may modulate inflammatory responses and immunity via inflammatory signaling pathways, including NF-&#x3ba;B Signaling (<xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B79">79</xref>) and TNF-&#x3b1; signaling (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B79">79</xref>), which are critical for maintaining reproductive health. By regulating the inflammatory response, CS can protect reproductive tissues from damage and promote healing.</p>
<p>Furthermore, CS affects oxidative stress, which is closely linked to inflammation. The polysaccharides and flavonoids found in CS exhibit antioxidant properties that protect reproductive cells from oxidative stress (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B35">35</xref>, <xref ref-type="bibr" rid="B52">52</xref>). Studies have indicated that these compounds can enhance the ability to scavenge free radicals, thereby reducing damage to spermatogenic cells and promoting testosterone secretion (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B16">16</xref>).</p>
</sec>
<sec id="s5_2_4">
<label>5.2.4</label>
<title>Apoptosis and cell death signaling</title>
<p>CS may regulate apoptosis by modulating pro- and anti-apoptotic proteins. By balancing these proteins, CS can influence cell survival and death in reproductive tissues, potentially protecting cells against stress-induced apoptosis (<xref ref-type="bibr" rid="B80">80</xref>). Proteins potentially involved in regulating apoptosis and cell death include pro-apoptotic proteins such as BAD, BAX, Cleaved Caspase 3, and CASP3, as well as those involved in regulating cell death (<xref ref-type="bibr" rid="B48">48</xref>). Cleaved Caspase 3 is linked to the regulation of the pro-apoptotic protein Bax (<xref ref-type="bibr" rid="B48">48</xref>). The anti-apoptotic protein BCL2 was also noted (<xref ref-type="bibr" rid="B54">54</xref>), along with the CSF/c-kit-PI3K-Bcl-2 pathway, which is a survival signaling pathway (<xref ref-type="bibr" rid="B46">46</xref>). All of these signaling pathways are closely associated with the physiology and pathology of reproductive endocrinologic systems.</p>
</sec>
<sec id="s5_2_5">
<label>5.2.5</label>
<title>Metabolic pathways</title>
<p>CS is involved in various metabolic pathways that are crucial for cellular energy production and material transformation. Key metabolic processes influenced by CS include carbohydrate breakdown and regulation of glucose uptake, which are essential for cellular energy production. CS may enhance metabolic activity, including starch and sucrose metabolism, as well as glucose transporter regulation (<xref ref-type="bibr" rid="B81">81</xref>), thereby supporting the energy demands of reproductive cells.</p>
<p>Amino acid metabolism includes tryptophan metabolism (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B82">82</xref>), phenylalanine metabolism (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B82">82</xref>), lysine degradation, vitamin B6 metabolism (<xref ref-type="bibr" rid="B4">4</xref>), and taurine and hypotaurine metabolism (<xref ref-type="bibr" rid="B4">4</xref>). CS may influence lipid synthesis and breakdown, which are crucial for maintaining the integrity of the cellular membrane and hormone production. Arachidonic acid metabolism is involved in inflammatory processes (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B83">83</xref>). Sphingomyelin metabolism is closely linked to lipid metabolism in cellular membranes (<xref ref-type="bibr" rid="B4">4</xref>).</p>
</sec>
<sec id="s5_2_6">
<label>5.2.6</label>
<title>Gene regulation</title>
<p>CS has been implicated in the regulation of gene expression through various mechanisms, including the modulation of transcription factors, such as the tumor suppressor p53 (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B71">71</xref>) and immediate-early gene transcription factors FOS (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B84">84</xref>) and JUN (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B48">48</xref>). By influencing these regulatory elements, CS can affect the expression of genes involved in reproductive processes, including hormone synthesis and cellular differentiation.</p>
</sec>
<sec id="s5_2_7">
<label>5.2.7</label>
<title>Epigenetic modifications</title>
<p>Research suggests that CS may play a role in epigenetic regulation, affecting gene expression without altering the DNA sequence, such as DNA methylation regulated by DNMT3L and DNA methyltransferase, which are involved in the regulation of epigenetic modifications (<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B73">73</xref>) and can affect cellular responses in the ovary (<xref ref-type="bibr" rid="B85">85</xref>) and reproductive health.</p>
</sec>
<sec id="s5_2_8">
<label>5.2.8</label>
<title>Cellular markers</title>
<p>CS may influence specific cellular markers that are crucial for identifying and classifying cell types in the reproductive system. These markers include proteins, enzymes, and other biomarkers involved in cellular function and differentiation. For example, CS affects Tartrate-resistant Acid Phosphatase 5b (TRACP-5b), a marker of bone resorption (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B86">86</xref>, <xref ref-type="bibr" rid="B87">87</xref>).</p>
</sec>
<sec id="s5_2_9">
<label>5.2.9</label>
<title>Other potential signals</title>
<p>CS also regulates other signals, including MMP9 in Tissue remodeling (<xref ref-type="bibr" rid="B20">20</xref>), Occudin in cell adhesion (<xref ref-type="bibr" rid="B42">42</xref>), OPG, and RANKL in bone remodeling (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B86">86</xref>&#x2013;<xref ref-type="bibr" rid="B88">88</xref>), cytokines (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B79">79</xref>), and cholinergic signaling in immune modulation (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B89">89</xref>).</p>
</sec>
</sec>
<sec id="s5_3">
<label>5.3</label>
<title>Integration of molecular mechanisms</title>
<p>Molecular mechanisms of several defined compounds in CS therapy for reproductive diseases have been documented, mainly including five primary chemical classes: polysaccharides, flavonoids, phenolic acids, fatty acids, and steroids. These different components play an important role in reproductive diseases through diverse signaling pathways (integrated in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>). There exists convergence in different signaling pathways in the treatment of reproductive diseases by CS. On one hand, different ingredients of CS converge on the same molecules via diverse signaling pathways or the same efficacy. For example, in male infertility, polysaccharides and flavonoids share the same HPG axis and MAPK pathway, and phenolic acids and flavonoids share the same Nrf2 pathway. Between female infertility and POI, RSA, or PCOS, phenolic acids and fatty acids share the arachidonic acid pathway. Between males and females, flavonoids play an important role via the same HPG axis, MAPK, and Nrf2 signaling pathways. Signaling crosstalk between different pathways may occur in relevant cells.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Integration of Molecular Mechanisms of CS Therapy for Reproductive Diseases. The schematic delineates the multifaceted pharmacological profile of CS by illustrating the interconnections among the documented bioactive constituents, underlying molecular mechanisms, and therapeutic efficacies in male infertility, female infertility, primary ovarian insufficiency (POI), polycystic ovary syndrome (PCOS), and recurrent spontaneous abortion (RSA). The figure illustrates that the signaling pathways associated with the five primary chemical classes originate from CS: polysaccharides (green), flavonoids (red), phenolic acids (blue), fatty acids (purple), and steroids (cyan). The lines without arrows represent the parallel relationships between different signal molecules.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-16-1659342-g005.tif">
<alt-text content-type="machine-generated">Flowchart depicting the molecular mechanisms of compounds of Cuscutae Semen (CS), polysaccharides, flavonoids, phenolic acids, fatty acids, and steroids. Arrows indicate signaling pathways through HPG axis, oxidative stress, inflammatory signaling, metabolic pathways, and hormone synthesis, playing an essential role in treating male and female infertility, POI, PCOS, and RSA.</alt-text>
</graphic>
</fig>
<p>CS influences the reproductive system through complex interactions between targeted molecules and signaling pathways. Such interactions result in a wide range of physiological responses. The effect of CS on the reproductive system is further highlighted by its ability to regulate key proteins or receptors. The intricate mechanisms through which CS exerts its effects underscore its potential as a valuable therapeutic agent for various reproductive disorders.</p>
</sec>
</sec>
<sec id="s6">
<label>6</label>
<title>Other profiles of CS</title>
<sec id="s6_1">
<label>6.1</label>
<title>Toxicity and safety</title>
<p>The toxicity and safety of CS have been investigated (<xref ref-type="bibr" rid="B90">90</xref>). <italic>Cuscuta chinensis</italic> Lam. water extract (CLW) is safe for ICR mice when the dose is lower than 1250 mg/kg (<xref ref-type="bibr" rid="B90">90</xref>); the LD<sub>50</sub> (median lethal dose), reflecting acute toxicity, was over 5000 mg/kg in ICR mice; and subacute toxicity results showed no mouse death or severe toxic reactions. Some indicators changed when different doses were tested in the study: the body weight at doses of 1250, 2500, and 5000 mg/kg CLW in both male and female mice was reduced, and only the feed intake of female mice was reduced; only at the 2500 mg/kg and 5000 mg/kg doses, CLW had very few organ coefficients involving organs such as the brain, liver, lungs, testes (males), and thymus; decreased platelet count, lymphocyte count, and hematocrit and increased neutrophil count; and affected liver functions, increasing aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP), and decreasing albumin, total cholesterol, and triglycerides; only at the 5000 mg/kg dose, daily oral administration of CLW induced mild toxic effects on the liver in both sexes, which may be a matter of concern (<xref ref-type="bibr" rid="B90">90</xref>).</p>
<p>CS has low toxicity and is considered safe because its safe dosage is significantly higher than the 6&#x2013;12 g of dried crude herb recommended daily for humans by the China Pharmacopoeia, although standardized dosing guidelines are not well established. At a dosage of 1250 mg/kg CLW, the safe dosage in mice (<xref ref-type="bibr" rid="B90">90</xref>) may be converted to approximately 6.6 grams CLW per day in humans, according to the standard for inter-species dose conversion using the body surface area normalization method. Furthermore, 1250 mg/kg in CLW is 16.2 times (estimated from 6.17% extraction yield) concentrated from the aqueous extract of dried crude herb (<xref ref-type="bibr" rid="B90">90</xref>), so 6.6 grams CLW each day in humans is equivalent to 106.9 grams dried crude herb, which is much higher than the dosage recommended by the China Pharmacopoeia, which also suggests that the Pharmacopoeia dose is safe. According to the safe dosage, it is speculated that the adverse effects of CS in humans are very few, although there is limited information on the adverse effects of CS in humans.</p>
</sec>
<sec id="s6_2">
<label>6.2</label>
<title>Composition consistency</title>
<p>The consistency of the diverse chemical compositions of CS should be considered. CS contains a wide and distinct array of flavonoids, chlorogenic acids, and lignans (<xref ref-type="bibr" rid="B23">23</xref>), as demonstrated by multiple analysis methods. Despite this diversity, the consistent presence of key components, such as chlorogenic acid and quercetin, across various samples indicates a higher degree of uniformity in chemical composition and potential therapeutic benefits (<xref ref-type="bibr" rid="B88">88</xref>). Notably, chemical profiles vary by species (e.g., <italic>C. chinensis</italic> vs. <italic>C. australis</italic>), host plants, and geographical location (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B34">34</xref>). Therefore, the standardization of marker compounds is essential. For example, hyperoside, as recommended by the China Pharmacopoeia, is used to distinguish <italic>C. chinensis</italic> from astragalin in <italic>C. australis</italic> (<xref ref-type="bibr" rid="B24">24</xref>). For future applications of CS, it is necessary to clarify its origin, develop cultivation protocols to reduce variability, develop different key compound markers for robust quality control and prediction, and conduct clinical RCTs using standardized extracts.</p>
</sec>
<sec id="s6_3">
<label>6.3</label>
<title>Herb-drug interaction</title>
<p>CS may be involved in herb-drug interactions, including hormonal drugs, antidiabetic drugs, immunosuppressants, and drug metabolism, although most interactions are based on preclinical studies or theoretical mechanisms. 1) The hormonal drug flavonoids from CS can promote testosterone secretion and expression of androgen receptor (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B18">18</xref>), ER, and progesterone receptor (<xref ref-type="bibr" rid="B61">61</xref>) owing to their effects on the HPG Axis. Thus, it may affect the outcomes of hormonal therapies, such as dydrogesterone treatment (<xref ref-type="bibr" rid="B64">64</xref>), including other potential oral contraceptives and hormone replacement therapy, although the evidence is limited. 2) Antidiabetic drugs: A study found that the CS extract reduced blood glucose levels in streptozotocin-induced diabetic rats (<xref ref-type="bibr" rid="B91">91</xref>), suggesting synergistic effects with hypoglycemic agents. Concurrent use with antidiabetic drugs may potentiate hypoglycemia, increasing the risk of low blood sugar. 3) The immunosuppressant kaempferol from CS attenuates the function of dendritic cells in the immune system (<xref ref-type="bibr" rid="B7">7</xref>) and inhibits inflammatory factors such as TNF-&#x3b1; and IL-6 (<xref ref-type="bibr" rid="B57">57</xref>). When used in conjunction with immunosuppressants, CS may counteract the immunosuppressive effects of the drugs. 4) The enzymes critical for drug metabolism, flavonoids in CS, may interact with cytochrome P450 (<xref ref-type="bibr" rid="B92">92</xref>) and carboxylesterases 2, which affect the metabolism of ester-containing drugs (<xref ref-type="bibr" rid="B93">93</xref>). This suggests that CS can alter the function of drug-metabolizing enzymes and plasma levels of drugs metabolized by these enzymes, even altering their efficacy or toxicity. Therefore, CS should be applied at a safe dosage, with caution to avoid potential herb-drug interactions with specific drugs.</p>
</sec>
</sec>
<sec id="s7" sec-type="conclusions">
<label>7</label>
<title>Conclusion and future direction</title>
<p>In summary, <italic>CS</italic> has a wide range of regulatory effects on the reproductive system through its multiple active ingredients, and its mechanism of action involves the comprehensive regulation of reproductive endocrine systems and multiple signaling pathways. The evidence presented in this review consistently points towards flavonoids as one of the primary material bases for CS&#x2019;s efficacy across various reproductive disorders. However, the contribution of other ingredients to therapeutic efficacy is being studied and discovered. For example, flavonoids modulate the HPG axis, inhibit POI progression via the PI3K-AKT pathway, regulate inflammation in RSA, and improve hormonal balance in PCOS models. Furthermore, this review also discussed the insistence of CS&#x2019;s traditional applications with the understanding of modern medicine: treating kidney yang deficiency aligns mechanistically with its ability to upregulate testosterone synthesis (<xref ref-type="bibr" rid="B18">18</xref>) and rescue oxidative stress in spermatogenic cells (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B35">35</xref>); menstrual regulation in TCM corresponds to CS-induced follicular development via FSH receptor sensitization (<xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B60">60</xref>). This review focuses on the treatment of reproductive endocrine diseases, potential signaling pathways, and the underlying molecular mechanisms of CS action, thereby bridging the gap between traditional knowledge and modern medicine. This study provides a crucial scientific foundation for the application of CS in the treatment of reproductive disorders.</p>
<p>There are still many limitations that need to be addressed in future research. Continued efforts to elucidate the precise molecular mechanisms of action, including the identification of specific cellular targets, receptors, and downstream signaling events involved in the effects of CS on reproductive tissues and endocrine function, are also warranted. Comprehensive pharmacokinetic and pharmacodynamic studies should be performed to fully elucidate the absorption, distribution, metabolism, and excretion of key CS compounds. The potential synergistic or antagonistic effects of the various compounds present in CS, which are crucial for optimizing therapeutic formulations, including herb-drug interactions, should be investigated through both <italic>in vitro</italic> and <italic>in vivo</italic> studies. The translation of encouraging preclinical findings into evidence-based clinical recommendations through rigorous human studies remains a critical next step in harnessing the therapeutic potential of CS in reproductive endocrine health. Furthermore, well-designed and adequately powered randomized controlled clinical trials of CS monotherapy are essential to rigorously evaluate the efficacy and safety of standardized CS extracts or isolated compounds for the treatment of specific reproductive endocrine diseases in humans.</p>
<p>Future studies should explore the optimal dosage, formulation (including the potential for targeted delivery), and duration of CS-based interventions for different reproductive endocrine disorders. Finally, investigating the potential of CS to address specific symptoms and subtypes of reproductive endocrine disorders will contribute to a more refined and personalized approach for its therapeutic application. For CS to be developed into a standardized modern therapeutic, future studies must focus on developing standardized extracts with consistent chemical profiles and predictable efficacy, which is essential for ensuring the safety and reproducibility of clinical outcomes.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>KL: Conceptualization, Funding acquisition, Project administration, Supervision, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. HZ: Writing &#x2013; review &amp; editing. WH: Writing &#x2013; review &amp; editing. YK: Writing &#x2013; review &amp; editing. QZ: Conceptualization, Funding acquisition, Project administration, Supervision, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research and/or publication of this article. This research was funded by the Clinical and Basic Joint Research Project of ZJPPH (C-2023-YXLH11) and the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents (Year 2018). APC was funded by the Clinical and Basic Joint Research Project of ZJPPH (grant number C-2023-YXLH11).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>The authors would like to thank the funding sources, Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents, and Clinical and Basic Joint Research Project of ZJPPH.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that Generative AI was used in the creation of this manuscript. The partial text has only been polished by Grammarly (Ver 6.8.263) and Paperpal.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec id="s12" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xin</surname> <given-names>G</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zong</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Song</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Research progress on chemical components and pharmacological effects of Cuscuta chinensis and prediction of its quality markers (Q-markers)</article-title>. <source>Chin Herbal Med</source>. (<year>2024</year>) <volume>55</volume>:<page-range>5298&#x2013;314</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.7501/j.issn.0253-2670.2024.15.029</pub-id>
</citation></ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ju</surname> <given-names>IG</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>N</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>JG</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>JK</given-names>
</name>
<name>
<surname>Oh</surname> <given-names>MS</given-names>
</name>
</person-group>. <article-title>Cuscutae Japonicae semen ameliorates memory dysfunction by rescuing synaptic damage in Alzheimer&#x2019;s disease models</article-title>. <source>Nutrients</source>. (<year>2019</year>) <volume>11</volume>:<elocation-id>2591</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu11112591</pub-id>, PMID: <pub-id pub-id-type="pmid">31661844</pub-id></citation></ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>Q</given-names>
</name>
<name>
<surname>An</surname> <given-names>R</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>XY</given-names>
</name>
<etal/>
</person-group>. <article-title>Anti-osteoporosis effect of Semen Cuscutae in ovariectomized mice through inhibition of bone resorption by osteoclasts</article-title>. <source>J Ethnopharmacol</source>. (<year>2022</year>) <volume>285</volume>:<elocation-id>114834</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2021.114834</pub-id>, PMID: <pub-id pub-id-type="pmid">34801609</pub-id></citation></ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname> <given-names>RH</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>CG</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>MQ</given-names>
</name>
<name>
<surname>Han</surname> <given-names>YM</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Metabolomics analysis of Semen Cuscutae protection of kidney deficient model rats using ultra high-performance liquid chromatography-quadrupole time-of-flight Mass Spectrometry</article-title>. <source>J Pharm BioMed Anal</source>. (<year>2022</year>) <volume>207</volume>:<elocation-id>114432</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jpba.2021.114432</pub-id>, PMID: <pub-id pub-id-type="pmid">34715580</pub-id></citation></ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Di</surname> <given-names>YM</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Oral Chinese Herbal Medicine plus usual care for diabetic kidney disease: study protocol for a randomized, double-blind, placebo-controlled pilot trial</article-title>. <source>Front Endocrinol (Lausanne)</source>. (<year>2024</year>) <volume>15</volume>:<elocation-id>1334609</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2024.1334609</pub-id>, PMID: <pub-id pub-id-type="pmid">38390199</pub-id></citation></ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Involvement of estrogen receptor activation in kaempferol-3-O-glucoside&#x2019;s protection against aging-related cognition impairment and microglial inflammation</article-title>. <source>Exp Cell Res</source>. (<year>2023</year>) <volume>433</volume>:<elocation-id>113849</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.yexcr.2023.113849</pub-id>, PMID: <pub-id pub-id-type="pmid">37926343</pub-id></citation></ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>MK</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>YL</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>KC</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>WT</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>MJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Kaempferol from Semen cuscutae attenuates the immune function of dendritic cells</article-title>. <source>Immunobiology</source>. (<year>2011</year>) <volume>216</volume>:<page-range>1103&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.imbio.2011.05.002</pub-id>, PMID: <pub-id pub-id-type="pmid">21621872</pub-id></citation></ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>MK</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>HC</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>TJ</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>YD</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>CR</given-names>
</name>
</person-group>. <article-title>Cuscuta chinensis and C. campestris attenuate Scopolamine-induced memory deficit and oxidative damage in mice</article-title>. <source>Molecules</source>. (<year>2018</year>) <volume>23</volume>:<elocation-id>3060</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules23123060</pub-id>, PMID: <pub-id pub-id-type="pmid">30467292</pub-id></citation></ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Purification, characterization and biological effect of reversing the kidney-yang deficiency of polysaccharides from semen cuscutae</article-title>. <source>Carbohydr Polym</source>. (<year>2017</year>) <volume>175</volume>:<page-range>249&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.carbpol.2017.07.077</pub-id>, PMID: <pub-id pub-id-type="pmid">28917863</pub-id></citation></ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Ning</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Guan</surname> <given-names>Y-H</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>N</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>S-Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Quercetin and flavonoids from Cuscuta chinensis lam. inhibit tripteryg ium glycoside-induced premature ovarian failure progression via PI3K-A</article-title>. <source>Pharmacogn Mag</source>. (<year>2021</year>) <volume>17</volume>:<page-range>475&#x2013;81</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4103/pm.pm_25_20</pub-id>
</citation></ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donnapee</surname> <given-names>S</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Ge</surname> <given-names>AH</given-names>
</name>
<name>
<surname>Donkor</surname> <given-names>PO</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>XM</given-names>
</name>
<etal/>
</person-group>. <article-title>Cuscuta chinensis Lam.: A systematic review on ethnopharmacology, phytochemistry and pharmacology of an important traditional herbal medicine</article-title>. <source>J Ethnopharmacol</source>. (<year>2014</year>) <volume>157</volume>:<fpage>292</fpage>&#x2013;<lpage>308</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2014.09.032</pub-id>, PMID: <pub-id pub-id-type="pmid">25281912</pub-id></citation></ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>DN</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>LY</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>MY</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>W</given-names>
</name>
<etal/>
</person-group>. <article-title>Complementary and alternative medicine for premature ovarian insufficiency: A review of utilization and mechanisms</article-title>. <source>Evid Based Complement Alternat Med</source>. (<year>2022</year>) <volume>2022</volume>:<elocation-id>9053930</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2022/9053930</pub-id>, PMID: <pub-id pub-id-type="pmid">35399635</pub-id></citation></ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname> <given-names>W</given-names>
</name>
<name>
<surname>Lei</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>Q</given-names>
</name>
</person-group>. <article-title>Mechanisms underlying the therapeutic effects of Semen cuscutae in treating recurrent spontaneous abortion based on network pharmacology and molecular docking</article-title>. <source>Front Mol Biosci</source>. (<year>2024</year>) <volume>11</volume>:<elocation-id>1282100</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmolb.2024.1282100</pub-id>, PMID: <pub-id pub-id-type="pmid">38872917</pub-id></citation></ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>X</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Advances in cytokine-based herbal medicine against premature ovarian insufficiency: A review</article-title>. <source>J Ethnopharmacol</source>. (<year>2024</year>) <volume>333</volume>:<elocation-id>118477</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2024.118477</pub-id>, PMID: <pub-id pub-id-type="pmid">38909824</pub-id></citation></ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ou</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Q</given-names>
</name>
</person-group>. <article-title>Effects of flavonoids from semen Cuscutae on changes of beta-EP in hypothalamuses and FSH and LH in anterior pituitaries in female rats exposed to psychologic stress</article-title>. <source>Zhong Yao Cai</source>. (<year>2002</year>) <volume>25</volume>:<page-range>886&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.13863/j.issn1001-4454.2002.12.015</pub-id>, PMID: <pub-id pub-id-type="pmid">12685350</pub-id></citation></ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Jiao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Bao</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Cuscuta chinensis flavonoids reducing oxidative stress of the improve sperm damage in bisphenol A exposed mice offspring</article-title>. <source>Ecotoxicol Environ Saf</source>. (<year>2023</year>) <volume>255</volume>:<fpage>114831</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ecoenv.2023.114831</pub-id>, PMID: <pub-id pub-id-type="pmid">36966614</pub-id></citation></ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname> <given-names>F</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Exploring the mechanism of (-)-Epicatechin on premature ovarian insufficiency based on network pharmacology and experimental evaluation</article-title>. <source>Biosci Rep</source>. (<year>2021</year>) <volume>41</volume>:<fpage>BSR20203955</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1042/BSR20203955</pub-id>, PMID: <pub-id pub-id-type="pmid">33521822</pub-id></citation></ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Bao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>The total flavones from Semen cuscutae reverse the reduction of testosterone level and the expression of androgen receptor gene in kidney-yang deficient mice</article-title>. <source>J Ethnopharmacol</source>. (<year>2008</year>) <volume>119</volume>:<page-range>166&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2008.06.027</pub-id>, PMID: <pub-id pub-id-type="pmid">18640256</pub-id></citation></ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>D</given-names>
</name>
<name>
<surname>Shang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Assessing themechanism of action of &#x201c;Fructus Ligustri Lucidi-Cuscutae Semen&#x201d; in prostate cancer treatment using network pharmacology and molecular docking</article-title>. <source>Comput Math Methods Med</source>. (<year>2022</year>) <volume>2022</volume>:<fpage>1</fpage>&#x2013;<lpage>16</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2022/9519864</pub-id>, PMID: <pub-id pub-id-type="pmid">36330452</pub-id></citation></ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname> <given-names>F</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>C</given-names>
</name>
<name>
<surname>Qiu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Total flavonoids from Semen Cuscutae target MMP9 and promote invasion of EVT cells via Notch/AKT/MAPK signaling pathways</article-title>. <source>Sci Rep</source>. (<year>2018</year>) <volume>8</volume>:<fpage>17342</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598-018-35732-6</pub-id>, PMID: <pub-id pub-id-type="pmid">30478366</pub-id></citation></ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>HW</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>DY</given-names>
</name>
<name>
<surname>Qiu</surname> <given-names>WY</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>QY</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>LL</given-names>
</name>
<etal/>
</person-group>. <article-title>Effect of total flavones from Cuscuta chinensis on anti-abortion via the MAPK signaling pathway</article-title>. <source>Evid Based Complement Alternat Med</source>. (<year>2018</year>) <volume>2018</volume>:<elocation-id>6356190</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2018/6356190</pub-id>, PMID: <pub-id pub-id-type="pmid">30369955</pub-id></citation></ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>M</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ji</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Characterization and analysis of Semen Cuscutae by capillary gas chromatography and gas chromatography-mass spectrometry</article-title>. <source>J Sep Sci</source>. (<year>2002</year>) <volume>25</volume>:<page-range>255&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jssc.200290030</pub-id>
</citation></ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xiong</surname> <given-names>H</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Xue</surname> <given-names>X</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Compounds identification in Semen Cuscutae by Ultra-High-Performance Liquid Chromatography (UPLCs) coupled to electrospray ionization mass spectrometry</article-title>. <source>Molecules</source>. (<year>2018</year>) <volume>23</volume>:<elocation-id>1199</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules23051199</pub-id>, PMID: <pub-id pub-id-type="pmid">29772791</pub-id></citation></ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>De An</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Characterization of phenolic compounds in the Chinese herbal drug Tu-Si-Zi by liquid chromatography coupled to electrospray ionization mass spectrometry</article-title>. <source>Rapid Commun Mass Spectrom</source>. (<year>2005</year>) <volume>19</volume>:<page-range>1469&#x2013;84</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/rcm.1580</pub-id>, PMID: <pub-id pub-id-type="pmid">15880618</pub-id></citation></ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>ZH</given-names>
</name>
<name>
<surname>Li</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Li</surname> <given-names>BJ</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Li</surname> <given-names>XG</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Deciphering the therapeutic mechanisms of Wuzi Yanzong Pill for asthenozoospermia: A synergistic approach combining bioinformatics and molecular dynamics</article-title>. <source>Cell Biochem Biophys</source>. (<year>2025</year>). doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12013-025-01835-x</pub-id>, PMID: <pub-id pub-id-type="pmid">40783635</pub-id></citation></ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>G</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>W</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Development of a HPLC-MS/MS method to determine the 13 elements of Semen Cuscutae and application to a pharmacokinetic study in rats</article-title>. <source>Evid Based Complement Alternat Med</source>. (<year>2019</year>) <volume>2019</volume>:<fpage>1</fpage>&#x2013;<lpage>11</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2019/3816304</pub-id>, PMID: <pub-id pub-id-type="pmid">31885656</pub-id></citation></ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>HB</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>JQ</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>N</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>JQ</given-names>
</name>
</person-group>. <article-title>Study of quality control on Cuscuta chinensis and C. Australia</article-title>. <source>Zhong Yao Cai</source>. (<year>2007</year>) <volume>30</volume>:<page-range>1446&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.13863/j.issn1001-4454.2007.11.034</pub-id>, PMID: <pub-id pub-id-type="pmid">18323218</pub-id></citation></ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>M</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Song</surname> <given-names>H</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Sui</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Reverse traceability analysis of estrogenic active ingredients in Cuscutae semen based on intestinal and hepatic metabolism</article-title>. <source>J Pharm BioMed Anal</source>. (<year>2025</year>) <volume>260</volume>:<elocation-id>116819</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jpba.2025.116819</pub-id>, PMID: <pub-id pub-id-type="pmid">40090130</pub-id></citation></ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>MN</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>TY</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>WJ</given-names>
</name>
<name>
<surname>Han</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Comparative studies on chemical contents and effect in kidney-yang deficiency rats of salt-processed product and wine-processed product of cuscutae semen</article-title>. <source>Evid Based Complement Alternat Med</source>. (<year>2019</year>) <volume>2019</volume>:<elocation-id>2049497</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2019/2049497</pub-id>, PMID: <pub-id pub-id-type="pmid">31558908</pub-id></citation></ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>B</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S</given-names>
</name>
<name>
<surname>Li</surname> <given-names>T</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>The difference of chemical components and biological activities of the crude products and the salt-processed product from Semen Cuscutae</article-title>. <source>Evid Based Complement Alternat Med</source>. (<year>2016</year>) <volume>2016</volume>:<elocation-id>8656740</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2016/8656740</pub-id>, PMID: <pub-id pub-id-type="pmid">27610186</pub-id></citation></ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yue</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Li</surname> <given-names>R</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Gong</surname> <given-names>C</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Determination and analysis of trace elements in Cuscuta</article-title>. <source>Beverage Indus</source>. (<year>2014</year>) <volume>000</volume>:<page-range>46&#x2013;9</page-range>.</citation></ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>H</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ran</surname> <given-names>M</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Comparative study on amino acids of four kinds of Cuscuta seeds in Shandong</article-title>. <source>Shizhen Tradit Chin Med</source>. (<year>2001</year>) <volume>12</volume>:<fpage>195</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3969/j.issn.1008-0805.2001.03.002</pub-id>
</citation></ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>John</surname> <given-names>NA</given-names>
</name>
<name>
<surname>Joseph</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Role of herbal, nutraceutical and synthetic agents in oligoasthenoteratozoospermia: A comparative assessment</article-title>. <source>NRFHH</source>. (<year>2023</year>) <volume>3</volume>:<fpage>293</fpage>&#x2013;<lpage>314</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.53365/nrfhh/166370</pub-id>
</citation></ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname> <given-names>I</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>G</given-names>
</name>
<name>
<surname>Moon</surname> <given-names>BC</given-names>
</name>
<name>
<surname>Song</surname> <given-names>JH</given-names>
</name>
</person-group>. <article-title>An integrated approach for efficient and accurate medicinal cuscutae semen identification</article-title>. <source>Plants (Basel)</source>. (<year>2020</year>) <volume>9</volume>:<elocation-id>1410</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/plants9111410</pub-id>, PMID: <pub-id pub-id-type="pmid">33105814</pub-id></citation></ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname> <given-names>H</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>P</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Effect of total flavonoids of Cuscuta chinensis Lam. (Convolvulaceae) on oxidative stress injury in mouse testis and epididymis, and on serum levels of reproductive hormones in oligoasthenospermia mice model</article-title>. <source>Trop J Pharm Res</source>. (<year>2021</year>) <volume>18</volume>:<page-range>1253&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4314/tjpr.v18i6.15</pub-id>
</citation></ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiu</surname> <given-names>W</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>F</given-names>
</name>
<name>
<surname>Wan</surname> <given-names>X</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>Research overview of classic prescription Wuzi Yanzong Pill in the treatment of male infertility</article-title>. <source>J Pract Trad Chin Inter Med</source>. (<year>2025</year>). Available online at: <uri xlink:href="https://link.cnki.net/urlid/21.1187.R.20250530.1135.008">https://link.cnki.net/urlid/21.1187.R.20250530.1135.008</uri> (<access-date>Accessed May 30, 2025</access-date>).</citation></ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Che</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>J-Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Song</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>S-L</given-names>
</name>
</person-group>. <article-title>Research progress on the application of the main components of Cuscuta sinensis in the urogenital system</article-title>. <source>Pharmacol Discov</source>. (<year>2023</year>) <volume>3</volume>:<page-range>12&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.53388/PR202303012</pub-id>
</citation></ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Observation on the effect of modified Cistanche Cuscuta Pills in treating endometrial hyperplasia according to symptoms</article-title>. <source>Pract Gynecol Endocrinol</source>. (<year>2022</year>) <volume>9</volume>:<fpage>88</fpage>&#x2013;<lpage>91</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3969/j.issn.2095-8803.2022.06.025</pub-id>
</citation></ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Treatment of 56 cases of light-weight polycystic ovary syndrome with modified Cistanche Cuscuta chinensis pills</article-title>. <source>Sichuan Tradit Chin Med</source>. (<year>2011</year>) <volume>29</volume>:<page-range>90&#x2013;1</page-range>.</citation></ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Observation on the efficacy of Shoutai Pills in treating 40 cases of fetal leakage and fetal movement disorder</article-title>. <source>Chin Prac Med</source>. (<year>2018</year>) <volume>13</volume>:<page-range>140&#x2013;1</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.14163/j.cnki.11-5547/r.2018.15.083</pub-id>
</citation></ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hung</surname> <given-names>YC</given-names>
</name>
<name>
<surname>Kao</surname> <given-names>CW</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>CC</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>YN</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>BY</given-names>
</name>
<name>
<surname>Hung</surname> <given-names>IL</given-names>
</name>
<etal/>
</person-group>. <article-title>Chinese herbal products for female infertility in Taiwan: A population-based cohort study</article-title>. <source>Med (Baltimore)</source>. (<year>2016</year>) <volume>95</volume>:<fpage>e3075</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MD.0000000000003075</pub-id>, PMID: <pub-id pub-id-type="pmid">26986137</pub-id></citation></ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>CX</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>SQ</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>K</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>The effect of semen cuscutae flavonoid on Sertoli cells and blood-testis barrier in male infertility: integrating network pharmacology and experimental verification</article-title>. <source>Pharm Biol</source>. (<year>2023</year>) <volume>61</volume>:<page-range>986&#x2013;99</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/13880209.2023.2229380</pub-id>, PMID: <pub-id pub-id-type="pmid">37386769</pub-id></citation></ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hyun</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Park</surname> <given-names>JY</given-names>
</name>
</person-group>. <article-title>Herbal therapeutics for female infertility: A systematic review and meta-analysis</article-title>. <source>J Ethnopharmacol</source>. (<year>2024</year>) <volume>319</volume>:<elocation-id>117258</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2023.117258</pub-id>, PMID: <pub-id pub-id-type="pmid">37778518</pub-id></citation></ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname> <given-names>S</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>L</given-names>
</name>
<name>
<surname>Xing</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Molecular mechanism of Cuscutae semen-radix rehmanniae praeparata in relieving reproductive injury of male rats induced with tripterygium wilfordii multiglycosides: A tandem mass tag-based proteomics analysis</article-title>. <source>Front Pharmacol</source>. (<year>2023</year>) <volume>14</volume>:<elocation-id>1050907</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2023.1050907</pub-id>, PMID: <pub-id pub-id-type="pmid">36874004</pub-id></citation></ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname> <given-names>EW</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>CY</given-names>
</name>
</person-group>. <article-title>Impacts of environmental toxicants on male reproductive dysfunction</article-title>. <source>Trends Pharmacol Sci</source>. (<year>2011</year>) <volume>32</volume>:<page-range>290&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.tips.2011.01.001</pub-id>, PMID: <pub-id pub-id-type="pmid">21324536</pub-id></citation></ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>A combination of Semen Cuscutae and Fructus Lycii improves testicular cell proliferation and inhibits their apoptosis in rats with spermatogenic dysfunction by regulating the SCF/c-kit-PI3K-Bcl2 pathway</article-title>. <source>J Ethnopharmacol</source>. (<year>2020</year>) <volume>251</volume>:<elocation-id>112525</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2019.112525</pub-id>, PMID: <pub-id pub-id-type="pmid">31904495</pub-id></citation></ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Su</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>XQ</given-names>
</name>
<name>
<surname>Li</surname> <given-names>WX</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Study on mechanism of Cuscutae Semen flavonoids in improving reproductive damage of Tripterygium Glycosides Tablets in rats based on high-throughput transcriptome sequencing</article-title>. <source>Zhongguo Zhong Yao Za Zhi</source>. (<year>2019</year>) <volume>44</volume>:<page-range>3478&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.19540/j.cnki.cjcmm.20190527.402</pub-id>, PMID: <pub-id pub-id-type="pmid">31602912</pub-id></citation></ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bao</surname> <given-names>B</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>F</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>S</given-names>
</name>
<name>
<surname>Dai</surname> <given-names>H</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>To study the mechanism of Cuscuta chinensis Lam. And Lycium barbarum L. in the treatment of asthenospermia based on network pharmacology</article-title>. <source>J Ethnopharmacol</source>. (<year>2021</year>) <volume>270</volume>:<fpage>113790</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2021.113790</pub-id>, PMID: <pub-id pub-id-type="pmid">33460759</pub-id></citation></ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sayed</surname> <given-names>SMA</given-names>
</name>
<name>
<surname>Alseekh</surname> <given-names>S</given-names>
</name>
<name>
<surname>Siems</surname> <given-names>K</given-names>
</name>
<name>
<surname>Fernie</surname> <given-names>AR</given-names>
</name>
<name>
<surname>Luyten</surname> <given-names>W</given-names>
</name>
<name>
<surname>Schmitz-Linneweber</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>Identification of a hydroxygallic acid derivative, zingibroside R1 and a sterol lipid as potential active ingredients of Cuscuta chinensis extract that has neuroprotective and antioxidant effects in aged Caenorhabditis elegans</article-title>. <source>Nutrients</source>. (<year>2022</year>) <volume>14</volume>:<elocation-id>4199</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu14194199</pub-id>, PMID: <pub-id pub-id-type="pmid">36235851</pub-id></citation></ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>G</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Shuai</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Acupoint stimulation and Chinese herbal medicines for the treatment of premature ovarian insufficiency: A systematic review and meta-analysis</article-title>. <source>Complement Ther Clin Pract</source>. (<year>2020</year>) <volume>41</volume>:<elocation-id>101244</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ctcp.2020.101244</pub-id>, PMID: <pub-id pub-id-type="pmid">33039750</pub-id></citation></ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>WC</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>YL</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>HC</given-names>
</name>
</person-group>. <article-title>Chinese herbal medicines have potentially beneficial effects on the perinatal outcomes of pregnant women</article-title>. <source>Front Pharmacol</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>831690</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2022.831690</pub-id>, PMID: <pub-id pub-id-type="pmid">35734397</pub-id></citation></ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>X</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>C</given-names>
</name>
<name>
<surname>Li</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Bushen Culuan Decoction ameliorates premature ovarian insufficiency by acting on the Nrf2/ARE signaling pathway to alleviate oxidative stress</article-title>. <source>Front Pharmacol</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>857932</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2022.857932</pub-id>, PMID: <pub-id pub-id-type="pmid">35462905</pub-id></citation></ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname> <given-names>XN</given-names>
</name>
<name>
<surname>Zong</surname> <given-names>LL</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Guan</surname> <given-names>YC</given-names>
</name>
<name>
<surname>Hao</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Effect of Cuscutae Semen and its major components flavones on kidney deficiency and ovulation inhibition in rats</article-title>. <source>Chin J Exp Tradit Med Formul</source>. (<year>2014</year>) <volume>20</volume>:<page-range>169&#x2013;72</page-range>.</citation></ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Teng</surname> <given-names>X</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Research progress on the effect of traditional chinese medicine on signal pathway related to premature ovarian insufficiency</article-title>. <source>Evid Based Complement Alternat Med</source>. (<year>2022</year>) <volume>2022</volume>:<elocation-id>7012978</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2022/7012978</pub-id>, PMID: <pub-id pub-id-type="pmid">36159578</pub-id></citation></ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Han</surname> <given-names>T</given-names>
</name>
<name>
<surname>Jia</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Pharmacokinetic/pharmacodynamic study of salt-processed product of cuscutae semen with hepatoprotective effects</article-title>. <source>Curr Drug Metab</source>. (<year>2022</year>) <volume>23</volume>:<page-range>964&#x2013;72</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2174/1389200224666221118112009</pub-id>, PMID: <pub-id pub-id-type="pmid">36411565</pub-id></citation></ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Han</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Song</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jin</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Cuscutae Semen in depression-induced ovarian dysfunction: metabolomics with UPLC-QToF-MS in female mice</article-title>. <source>Front Mol Biosci</source>. (<year>2025</year>) <volume>12</volume>:<elocation-id>1595602</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmolb.2025.1595602</pub-id>, PMID: <pub-id pub-id-type="pmid">40370520</pub-id></citation></ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>WT</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Chiu</surname> <given-names>YJ</given-names>
</name>
<name>
<surname>Chao</surname> <given-names>WK</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>YC</given-names>
</name>
<etal/>
</person-group>. <article-title>Antinociceptive and anti-inflammatory activities of cuscuta chinensis seeds in mice</article-title>. <source>Am J Chin Med</source>. (<year>2014</year>) <volume>42</volume>:<page-range>223&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1142/S0192415X14500153</pub-id>, PMID: <pub-id pub-id-type="pmid">24467546</pub-id></citation></ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suresh</surname> <given-names>V</given-names>
</name>
<name>
<surname>Sruthi</surname> <given-names>V</given-names>
</name>
<name>
<surname>Padmaja</surname> <given-names>B</given-names>
</name>
<name>
<surname>Asha</surname> <given-names>VV</given-names>
</name>
</person-group>. <article-title>
<italic>In vitro</italic> anti-inflammatory and anti-cancer activities of Cuscuta reflexa Roxb</article-title>. <source>J Ethnopharmacol</source>. (<year>2011</year>) <volume>134</volume>:<page-range>872&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2011.01.043</pub-id>, PMID: <pub-id pub-id-type="pmid">21295129</pub-id></citation></ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname> <given-names>HX</given-names>
</name>
<name>
<surname>You</surname> <given-names>ZL</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>XY</given-names>
</name>
</person-group>. <article-title>Effect of total flavones from Cuscuta chinensis on expression of Fas/FasL, PCNA and HB-EGF in SD rats model with bromocriptine-induced abortion</article-title>. <source>Zhong Yao Cai</source>. (<year>2008</year>) <volume>31</volume>:<fpage>1706-9</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.13863/j.issn1001-4454.2008.11.050</pub-id>, PMID: <pub-id pub-id-type="pmid">19260287</pub-id></citation></ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ke</surname> <given-names>J</given-names>
</name>
<name>
<surname>Duan</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Effects of flavonoids from semen cuscutae on the hippocampal-hypothalamic-pituitary-ovarian sex hormone receptors in female rats exposed to psychological stress</article-title>. <source>Clin Exp Obstet Gynecol</source>. (<year>2013</year>) <volume>40</volume>:<page-range>271&#x2013;4</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1556/CEOG.40.2013.2.10</pub-id>, PMID: <pub-id pub-id-type="pmid">23971257</pub-id></citation></ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>L</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Jian</surname> <given-names>L</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>The Modified Bushen Antai Recipe upregulates estrogen and progesterone receptors at the maternal-fetal interface in pregnant rats with mifepristone-induced pregnancy loss</article-title>. <source>Evid Based Complement Alternat Med</source>. (<year>2019</year>) <volume>2019</volume>:<elocation-id>8312020</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2019/8312020</pub-id>, PMID: <pub-id pub-id-type="pmid">30792746</pub-id></citation></ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>D</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>M</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>W</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>An analysis of the clinical medication rules of traditional chinese medicine for polycystic ovary syndrome based on data mining</article-title>. <source>Evid Based Complement Alternat Med</source>. (<year>2023</year>) <volume>2023</volume>:<elocation-id>6198001</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2023/6198001</pub-id>, PMID: <pub-id pub-id-type="pmid">36865746</pub-id></citation></ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>YY</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>JX</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>YT</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>YX</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>WQ</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Investigation of the mechanisms and experimental verification of Cuscuta-Salvia in the treatment of polycystic ovary syndrome (PCOS) via network pharmacology</article-title>. <source>J Ovarian Res</source>. (<year>2022</year>) <volume>15</volume>:<fpage>40</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13048-022-00964-8</pub-id>, PMID: <pub-id pub-id-type="pmid">35379295</pub-id></citation></ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>K</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>X</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
</person-group>. <article-title>Efficacy and safety of Gushen Antai Pills combined with dydrogesterone in the treatment of threatened miscarriage: a systematic review and meta-analysis</article-title>. <source>Front Pharmacol</source>. (<year>2023</year>) <volume>14</volume>:<elocation-id>1138968</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2023.1138968</pub-id>, PMID: <pub-id pub-id-type="pmid">37332346</pub-id></citation></ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duan</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Wuzi Yanzong Pill in the treatment of male oligoasthenospermia: A meta-analysis</article-title>. <source>J Yunnan Univ Chin Med</source>. (<year>2024</year>) <volume>47</volume>:<page-range>106&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.19288/j.cnki.issn.1000-2723.2024.04.018</pub-id>
</citation></ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Nie</surname> <given-names>G</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>F</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Efficacy and safety of HYYK formula for residual follicle revival in premature ovarian insufficiency: a multicenter, randomized, double-blind, placebo-controlled trial protocol</article-title>. <source>BMC Complement Med Ther</source>. (<year>2025</year>) <volume>25</volume>:<fpage>46</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12906-025-04803-3</pub-id>, PMID: <pub-id pub-id-type="pmid">39934764</pub-id></citation></ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>K</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Study on pharmacokinetic and tissue distribution of hyperin, astragalin, kaempferol-3-O-beta-D-glucuronide from rats with multiple administrations of Semen Cuscutae processed with salt solution with effect of treating recurrent spontaneous abortion</article-title>. <source>Front Pharmacol</source>. (<year>2024</year>) <volume>15</volume>:<elocation-id>1440810</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2024.1440810</pub-id>, PMID: <pub-id pub-id-type="pmid">39351087</pub-id></citation></ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abbara</surname> <given-names>A</given-names>
</name>
<name>
<surname>Dhillo</surname> <given-names>WS</given-names>
</name>
</person-group>. <article-title>Astrocytes: a star emerges in the control of reproductive hormones</article-title>. <source>J Clin Invest</source>. (<year>2024</year>) <volume>134</volume>:<fpage>e182669</fpage> doi:&#xa0;<pub-id pub-id-type="doi">10.1172/JCI182669</pub-id>, PMID: <pub-id pub-id-type="pmid">39087475</pub-id></citation></ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krause</surname> <given-names>BT</given-names>
</name>
<name>
<surname>Ohlinger</surname> <given-names>R</given-names>
</name>
<name>
<surname>Haase</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: a review</article-title>. <source>Biologics</source>. (<year>2009</year>) <volume>3</volume>:<page-range>337&#x2013;47</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/btt.2009.3306</pub-id>, PMID: <pub-id pub-id-type="pmid">19707419</pub-id></citation></ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname> <given-names>DN</given-names>
</name>
<name>
<surname>She</surname> <given-names>BR</given-names>
</name>
<name>
<surname>She</surname> <given-names>YC</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>JH</given-names>
</name>
</person-group>. <article-title>Effects of flavonoids from Semen Cuscutae on the reproductive system in male rats</article-title>. <source>Asian J Androl</source>. (<year>2000</year>) <volume>2</volume>:<fpage>99</fpage>&#x2013;<lpage>102</lpage>., PMID: <pub-id pub-id-type="pmid">11232800</pub-id></citation></ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>P</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Han</surname> <given-names>X</given-names>
</name>
<name>
<surname>She</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Network pharmacology and experimental validation to explore the molecular mechanisms of Bushen Huoxue for the treatment of premature ovarian insufficiency</article-title>. <source>Bioengineered</source>. (<year>2021</year>) <volume>12</volume>:<page-range>10345&#x2013;62</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/21655979.2021.1996317</pub-id>, PMID: <pub-id pub-id-type="pmid">34753385</pub-id></citation></ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname> <given-names>W</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>A network pharmacology approach to estimate the active ingredients and potential targets of Cuscutae semen in the treatment of osteoporosis</article-title>. <source>Med Sci Monit</source>. (<year>2020</year>) <volume>26</volume>:<elocation-id>e920485</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.12659/MSM.920485</pub-id>, PMID: <pub-id pub-id-type="pmid">32081843</pub-id></citation></ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Han</surname> <given-names>C</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Bao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>W</given-names>
</name>
</person-group>. <article-title>Cuscuta chinensis flavonoids down-regulate the DNA methylation of the H19/Igf2 imprinted control region and estrogen receptor alpha promoter of the testis in bisphenol A exposed mouse offspring</article-title>. <source>Food Funct</source>. (<year>2020</year>) <volume>11</volume>:<page-range>787&#x2013;98</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1039/C9FO02770J</pub-id>, PMID: <pub-id pub-id-type="pmid">31930238</pub-id></citation></ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>W</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Network pharmacology and molecular docking approach to reveal the immunotherapeutic mechanism of Cuscutae Semen in treating thin endometrium</article-title>. <source>J Immunol Res</source>. (<year>2022</year>) <volume>2022</volume>:<elocation-id>4333128</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2022/4333128</pub-id>, PMID: <pub-id pub-id-type="pmid">36249421</pub-id></citation></ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>J</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>B</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Chrysotoxine regulates ferroptosis and the PI3K/AKT/mTOR pathway to prevent cervical cancer</article-title>. <source>J Ethnopharmacol</source>. (<year>2025</year>) <volume>338</volume>:<elocation-id>119126</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2024.119126</pub-id>, PMID: <pub-id pub-id-type="pmid">39557107</pub-id></citation></ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname> <given-names>JY</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>HN</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>YR</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>BW</given-names>
</name>
<name>
<surname>Shin</surname> <given-names>HK</given-names>
</name>
<etal/>
</person-group>. <article-title>Aqueous fraction from Cuscuta japonica seed suppresses melanin synthesis through inhibition of the p38 mitogen-activated protein kinase signaling pathway in B16F10 cells</article-title>. <source>J Ethnopharmacol</source>. (<year>2012</year>) <volume>141</volume>:<page-range>338&#x2013;44</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2012.02.043</pub-id>, PMID: <pub-id pub-id-type="pmid">22414478</pub-id></citation></ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>K</given-names>
</name>
<name>
<surname>He</surname> <given-names>C</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>K</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>The effects and molecular mechanism of heat stress on spermatogenesis and the mitigation measures</article-title>. <source>Syst Biol Reprod Med</source>. (<year>2022</year>) <volume>68</volume>:<page-range>331&#x2013;47</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/19396368.2022.2074325</pub-id>, PMID: <pub-id pub-id-type="pmid">35722894</pub-id></citation></ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Li</surname> <given-names>L</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Fertility-enhancing potential of ethanol extract of Cuscuta chinensis seeds in a rat model of unilateral cryptorchidism</article-title>. <source>Trop J Pharm Res</source>. (<year>2022</year>) <volume>20</volume>:<fpage>995</fpage>&#x2013;<lpage>1002</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4314/tjpr.v20i5.16</pub-id>
</citation></ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname> <given-names>L</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Miao</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>W</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Cuscutae semen alleviates CUS-induced depression-like behaviors in mice via the gut microbiota-neuroinflammation axis</article-title>. <source>Front Pharmacol</source>. (<year>2023</year>) <volume>14</volume>:<elocation-id>1107781</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2023.1107781</pub-id>, PMID: <pub-id pub-id-type="pmid">36909192</pub-id></citation></ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname> <given-names>D</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Mao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Antagonistic effect of cuscuta chinensis on a rat model with unilateral cryptorchidism</article-title>. <source>Med Sci Monit</source>. (<year>2019</year>) <volume>25</volume>:<page-range>6727&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.12659/MSM.916893</pub-id>, PMID: <pub-id pub-id-type="pmid">31493333</pub-id></citation></ref>
<ref id="B81">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>L</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Atractylodes macrocephala Koidz. and Cuscuta chinensis Lam. extract relieves insulin resistance via PI3K/Akt signalling in diabetic Drosophila</article-title>. <source>J Tradit Complement Med</source>. (<year>2024</year>) <volume>14</volume>:<page-range>424&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jtcme.2024.01.010</pub-id>, PMID: <pub-id pub-id-type="pmid">39035690</pub-id></citation></ref>
<ref id="B82">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>H</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>S</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>F</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>An integrated approach to uncover quality markers of stir-baking Semen Cuscuta with salt solution preventing recurrent spontaneous abortion based on chemical and metabolomic profiling</article-title>. <source>J Chromatogr B Analyt Technol BioMed Life Sci</source>. (<year>2021</year>) <volume>1177</volume>:<elocation-id>122727</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jchromb.2021.122727</pub-id>, PMID: <pub-id pub-id-type="pmid">34102535</pub-id></citation></ref>
<ref id="B83">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bai</surname> <given-names>X</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>D</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>G</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>An integrated analysis of network pharmacology, molecular docking, and experiment validation to explore the new candidate active component and mechanism of Cuscutae Semen-Mori Fructus coupled-herbs in treating oligoasthenozoospermia</article-title>. <source>Drug Des Devel Ther</source>. (<year>2021</year>) <volume>15</volume>:<page-range>2059&#x2013;89</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/DDDT.S307015</pub-id>, PMID: <pub-id pub-id-type="pmid">34040346</pub-id></citation></ref>
<ref id="B84">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>H</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Weng</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>The preventive effect of Cuscutae Semen polysaccharide on bone loss in the ovariectomized rat model</article-title>. <source>BioMed Pharmacother</source>. (<year>2020</year>) <volume>130</volume>:<elocation-id>110613</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2020.110613</pub-id>, PMID: <pub-id pub-id-type="pmid">34321160</pub-id></citation></ref>
<ref id="B85">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zong</surname> <given-names>C</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>L</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>C-myc promotes miR-92a-2-5p transcription in rat ovarian granulosa cells after cadmium exposure</article-title>. <source>Toxicol Appl Pharmacol</source>. (<year>2021</year>) <volume>421</volume>:<elocation-id>115536</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.taap.2021.115536</pub-id>, PMID: <pub-id pub-id-type="pmid">33865896</pub-id></citation></ref>
<ref id="B86">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>G</given-names>
</name>
<name>
<surname>Niu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Comparative Investigation between raw and stir-frying processed Cuscutae Semen based on HPLC fingerprints coupled with chemometric methods</article-title>. <source>J AOAC Int</source>. (<year>2023</year>) <volume>106</volume>:<page-range>1037&#x2013;47</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jaoacint/qsad002</pub-id>, PMID: <pub-id pub-id-type="pmid">36610995</pub-id></citation></ref>
<ref id="B87">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>EY</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>EK</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Sohn</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Soh</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Jung</surname> <given-names>HS</given-names>
</name>
<etal/>
</person-group>. <article-title>Protective effects of Cuscutae semen against dimethylnitrosamine-induced acute liver injury in Sprague-Dawley rats</article-title>. <source>Biol Pharm Bull</source>. (<year>2007</year>) <volume>30</volume>:<page-range>1427&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1248/bpb.30.1427</pub-id>, PMID: <pub-id pub-id-type="pmid">17666798</pub-id></citation></ref>
<ref id="B88">
<label>88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mo</surname> <given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>N</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
<name>
<surname>Li</surname> <given-names>F</given-names>
</name>
<name>
<surname>Pu</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Beneficial effects of Cuscuta chinensis extract on glucocorticoid-induced osteoporosis through modulation of RANKL/OPG signals</article-title>. <source>Braz J Med Biol Res</source>. (<year>2019</year>) <volume>52</volume>:<page-range>e8754&#x2013;e</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1590/1414-431X20198754</pub-id>, PMID: <pub-id pub-id-type="pmid">31826180</pub-id></citation></ref>
<ref id="B89">
<label>89</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>V</given-names>
</name>
<name>
<surname>Chauhan</surname> <given-names>NS</given-names>
</name>
<name>
<surname>Dixit</surname> <given-names>VK</given-names>
</name>
</person-group>. <article-title>An updated review on the parasitic herb of Cuscuta reflexa Roxb</article-title>. <source>Zhong Xi Yi Jie He Xue Bao</source>. (<year>2012</year>) <volume>10</volume>:<page-range>249&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3736/jcim20120302</pub-id>, PMID: <pub-id pub-id-type="pmid">22409913</pub-id></citation></ref>
<ref id="B90">
<label>90</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maimaiti</surname> <given-names>A</given-names>
</name>
<name>
<surname>Li</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>L</given-names>
</name>
</person-group>. <article-title>Investigating the acute and sub-acute toxicity of medicinal Cuscuta chinensis Lam plant</article-title>. <source>J Ethnopharmacol</source>. (<year>2021</year>) <volume>273</volume>:<elocation-id>114005</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jep.2021.114005</pub-id>, PMID: <pub-id pub-id-type="pmid">33705922</pub-id></citation></ref>
<ref id="B91">
<label>91</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Seo</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Noh</surname> <given-names>BW</given-names>
</name>
<name>
<surname>He</surname> <given-names>MT</given-names>
</name>
<name>
<surname>Choi</surname> <given-names>YH</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>EJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Protective effects of Cuscuta chinensis Lam. extract against learning and memory dysfunction induced by streptozotocin and amyloid beta(25-35) <italic>in vivo</italic> model</article-title>. <source>Arch Physiol Biochem</source>. (<year>2025</year>), <fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/13813455.2025.2502861</pub-id> (<access-date>Accessed May 12, 2025</access-date>)., PMID: <pub-id pub-id-type="pmid">40353733</pub-id></citation></ref>
<ref id="B92">
<label>92</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>HH</given-names>
</name>
</person-group>. <article-title>Effects of the flavonoids on cytochrome P-450 CYP1, 2E1, 3A4 and 19</article-title>. <source>Yao Xue Xue Bao</source>. (<year>2007</year>) <volume>42</volume>:<fpage>8</fpage>&#x2013;<lpage>12</lpage>., PMID: <pub-id pub-id-type="pmid">17520800</pub-id></citation></ref>
<ref id="B93">
<label>93</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Song</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ge</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Carboxylesterases mediated herb-drug interactions: A systematic review</article-title>. <source>J TMR Mod Herb Med</source>. (<year>2019</year>) <volume>2</volume>:<fpage>147</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.12032/TMRmhm2017B40</pub-id>
</citation></ref>
</ref-list>
<glossary>
<title>Glossary</title>
<def-list>
<def-item>
<term>AR</term>
<def>
<p>Androgen Receptor</p>
</def>
</def-item>
<def-item>
<term>BAD</term>
<def>
<p>Bcl-2 Antagonist of Cell Death</p>
</def>
</def-item>
<def-item>
<term>BAX</term>
<def>
<p>Bcl-2-Associated X Protein</p>
</def>
</def-item>
<def-item>
<term>BCL2</term>
<def>
<p>B-cell Lymphoma 2</p>
</def>
</def-item>
<def-item>
<term>CASP3</term>
<def>
<p>Caspase 3</p>
</def>
</def-item>
<def-item>
<term>CCND1</term>
<def>
<p>Cyclin D1</p>
</def>
</def-item>
<def-item>
<term>CRF</term>
<def>
<p>Corticotropin-Releasing Factor</p>
</def>
</def-item>
<def-item>
<term>DNMT3 L</term>
<def>
<p>DNA Methyltransferase 3 Like</p>
</def>
</def-item>
<def-item>
<term>E2</term>
<def>
<p>Estradiol</p>
</def>
</def-item>
<def-item>
<term>EGF</term>
<def>
<p>Epidermal Growth Factor</p>
</def>
</def-item>
<def-item>
<term>EGFR</term>
<def>
<p>Epidermal Growth Factor Receptor</p>
</def>
</def-item>
<def-item>
<term>FOS</term>
<def>
<p>Fos Proto-Oncogene</p>
</def>
</def-item>
<def-item>
<term>FSH</term>
<def>
<p>Follicle-Stimulating Hormone</p>
</def>
</def-item>
<def-item>
<term>FSHR</term>
<def>
<p>Follicle-Stimulating Hormone Receptor</p>
</def>
</def-item>
<def-item>
<term>GnRH</term>
<def>
<p>Gonadotropin-Releasing Hormone</p>
</def>
</def-item>
<def-item>
<term>hCG</term>
<def>
<p>Human Chorionic Gonadotropin</p>
</def>
</def-item>
<def-item>
<term>HIF-1</term>
<def>
<p>Hypoxia-Inducible Factor 1</p>
</def>
</def-item>
<def-item>
<term>HIF1A</term>
<def>
<p>Hypoxia-Inducible Factor 1 Alpha</p>
</def>
</def-item>
<def-item>
<term>HPG</term>
<def>
<p>Hypothalamus-Pituitary-Gonadal</p>
</def>
</def-item>
<def-item>
<term>IL6</term>
<def>
<p>Interleukin 6</p>
</def>
</def-item>
<def-item>
<term>JUN</term>
<def>
<p>Jun Proto-Oncogene</p>
</def>
</def-item>
<def-item>
<term>Ki67</term>
<def>
<p>MKI67 (marker of proliferation Kiel 67)</p>
</def>
</def-item>
<def-item>
<term>LH</term>
<def>
<p>Luteinizing Hormone</p>
</def>
</def-item>
<def-item>
<term>LHR</term>
<def>
<p>Luteinizing Hormone Receptor</p>
</def>
</def-item>
<def-item>
<term>MAPK</term>
<def>
<p>Mitogen-Activated Protein Kinase</p>
</def>
</def-item>
<def-item>
<term>MMP9</term>
<def>
<p>Matrix Metalloproteinase 9</p>
</def>
</def-item>
<def-item>
<term>NF-&#x3ba;B</term>
<def>
<p>Nuclear Factor Kappa-B</p>
</def>
</def-item>
<def-item>
<term>Nrf2</term>
<def>
<p>Nuclear Factor Erythroid 2-Related Factor 2</p>
</def>
</def-item>
<def-item>
<term>OCCLUDIN</term>
<def>
<p>Occludin</p>
</def>
</def-item>
<def-item>
<term>OPG</term>
<def>
<p>Osteoprotegerin</p>
</def>
</def-item>
<def-item>
<term>PCOS</term>
<def>
<p>Polycystic Ovary Syndrome</p>
</def>
</def-item>
<def-item>
<term>PI3K/AKT</term>
<def>
<p>Phosphatidylinositol 3-Kinase/Akt</p>
</def>
</def-item>
<def-item>
<term>POI</term>
<def>
<p>Premature Ovarian Insufficiency</p>
</def>
</def-item>
<def-item>
<term>RANKL</term>
<def>
<p>Receptor Activator of Nuclear Factor-&#x3ba;B Ligand</p>
</def>
</def-item>
<def-item>
<term>RSA</term>
<def>
<p>Recurrent Spontaneous Abortion</p>
</def>
</def-item>
<def-item>
<term>SCF/c-kit&#x2013;PI3K&#x2013;Bcl-2</term>
<def>
<p>Stem Cell Factor/c-kit&#x2013;Phosphatidylinositol 3-Kinase&#x2013;Bcl-2</p>
</def>
</def-item>
<def-item>
<term>TCM</term>
<def>
<p>Traditional Chinese Medicine</p>
</def>
</def-item>
<def-item>
<term>TNF-&#x3b1;</term>
<def>
<p>Tumor Necrosis Factor-&#x3b1;</p>
</def>
</def-item>
<def-item>
<term>TP53</term>
<def>
<p>Tumor Protein 53</p>
</def>
</def-item>
<def-item>
<term>TRACP-5b</term>
<def>
<p>Tartrate-Resistant Acid Phosphatase 5b</p>
</def>
</def-item>
<def-item>
<term>VEGF</term>
<def>
<p>Vascular Endothelial Growth Factor</p>
</def>
</def-item>
<def-item>
<term>VEGFA</term>
<def>
<p>Vascular Endothelial Growth Factor A</p>
</def>
</def-item>
<def-item>
<term>&#x3b2;-EP</term>
<def>
<p>&#x3b2;-Endorphin</p>
</def>
</def-item>
</def-list>
</glossary>
</back>
</article>